Structural requirements for enzymatic efficiency in cofactor-independent decarboxylation by Desai, Bijoy
 
 
 
 
 
STRUCTURAL REQUIREMENTS FOR ENZYMATIC EFFICIENCY IN COFACTOR-
INDEPENDENT DECARBOXYLATION 
 
 
 
 
 
BY 
 
BIJOY J. DESAI 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Biochemistry 
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2014 
 
 
 
 
Urbana, Illinois 
 
Doctoral Committee: 
 
Professor John A. Gerlt, Chair 
Professor James H. Morrissey 
Professor Satish K. Nair 
Assistant Professor Rutilio A. Fratti 
 
 
ii 
Abstract 
     Orotidine 5’-monophosphate decarboxylase (OMPDC) is the last enzyme in the de 
novo pyrimidine biosynthetic pathway. It catalyzes the decarboxylation of orotidine 5’-
monophosphate (OMP) to uridine 5’-monophosphate (UMP), without the requirement of 
a cofactor. It provides catalytic rate enhancements of ~1017, compared to the 
uncatalyzed reaction, making it one of the most efficient enzymes known (1). OMPDC 
has thus been a paradigm to understand enzymatic catalysis. Yet, many aspects of its 
catalytic mechanism are not well understood. The reaction coordinate consists of a vinyl 
carbanion/carbene intermediate  (2). To characterize the interaction of the intermediate 
with the enzyme active site, I performed site-directed mutagenesis of Ser 127 to L-
glycerate residue (Chapter 2). This was accomplished by in vitro protein expression 
using L-glycerate charged tRNA. Examination of kinetic parameters of this mutant 
revealed that the backbone interactions accounts for 102 fold of the total 1017 fold rate 
enhancement (3). 
 
     OMPDC achieves its extraordinary rate enhancements by ground-state 
destabilization (GSD) and transition state destabilization (TSS) (4, 5). These strategies, 
enforced in the Michaelis complex, are accompanied by conformational changes, as 
characterized by the Apo (Eo) and inhibitor bound (Ec) crystal structures.  A hallmark of 
these conformational changes is the selective formation of interactions in the Ec form 
compared to Eo, by residues remote from the active site of the enzyme. The role of 
these conformational changes in OMPDC catalysis has not been fully understood. 
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     Using a combination of site-directed mutagenesis, substrate analogs, enzyme kinetic 
analysis and x-ray crystallographic analysis, research in Chapter 3 attempts to elucidate 
the mechanism for the formation of Ec from Eo. By comparing the second order rate 
constants (kcat/KM) for decarboxylation of OMP and a substrate analog devoid of 5’-
phosphate group (EO) for mutants of residues that interact with the 5’-phosphate group 
(Q185A and R203A) with those of wild-type enzyme, I have determined intrinsic binding 
energy (IBE) contributions of these residues. Using a similar analysis with mutants of 
remote residues that selectively form hydrogen bonding (T159V, R203A and Y206F) and 
hydrophobic (V182A) interactions in Ec, I have determined the energetic contribution of 
these interactions to the IBE. Combining each mutant of the “remote” interactions with 
that of phosphate binding interactions, I have established the energetic independence 
of the “remote” interactions from 5’-phosphate binding in increasing catalytic efficiency 
of the enzyme. Taken together, the results of this research have lead to a structural 
and kinetic model that explains the roles of substrate binding and conformational 
change in OMPDC catalysis (6). 
 
        In Chapter 4, I investigate whether FrsA can perform cofactor independent 
decarboxylation of pyruvate. FrsA, a member of α/β hydrolase superfamily, was 
reported to catalyze cofactor independent decarboxylation of pyruvate, in a manner 
similar to OMPDC (7). Our studies show convincing evidence that frsA is not capable of 
catalyzing decarboxylation of pyruvate and the earlier report is incorrect (8). 
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CHAPTER 1: GENERAL INTRODUCTION 
 
IMPORTANCE OF OMPDC IN ENZYMOLOGY 
Orotidine 5’-monophosphate decarboxylase is the last enzyme in the de-novo pyrimidine 
biosynthesis pathway. It catalyzes the conversion of orotidine 5’-monophosphate to 
uridine 5’-monophosphate, an essential precursor to pyrimidine ribonucleotides used for 
RNA synthesis as well as pyrimidine deoxyribonucleotides used for DNA synthesis. The 
product, UMP, acts as a feedback regulator for the de novo pyrimidine biosynthesis 
pathway (Figure 1). Due to its essential role in cellular physiology it is found in all 
domains of life (Figure 2). Its pivotal function in metabolism, OMPDC is an important 
target for anti-microbial drug discovery efforts. 
 
     Since its discovery, OMPDC has captured the interest of enzymologists due to its 
extraordinary catalytic prowess. Decarboxylation reactions are inherently difficult to 
perform as they usually form negatively charged intermediates that require stabilization. 
Most decarboxylases found in nature utilize either metal, pyridoxal phosphate or 
thiamine pyrophosphate as cofactors to stabilize the negative charge. In contrast, 
decarboxylation of OMP would proceed via a negatively charged vinyl anion 
intermediate, with no apparent means of internal stabilization. The rate of 
decarboxylation of uncatalyzed reaction was estimated by Beak et. al. and later by 
Lewis et. al., to be 5 X 10-14 and 3.4 X 10-15 respectively, making the estimated rate-
enhancement afforded by OMPDC ~1016 – 1017 fold (Figure 3) (1, 2). Until the 
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discovery of uroporphyrinogen III decarboxylase, OMPDC was the most efficient 
enzyme known. In spite of more than two decades of studies on OMPDC, the structural 
contributors to the 1017 fold rate enhancement have not been elucidated. 
 
 
Figure 1. De novo pyrimidine biosynthesis pathway. 
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Figure 2. Sequence similarity network of all OMPDC protein sequences. Each node 
represents a unique protein sequence. Nodes that have sequences similarity less than 
or equal to a blast-e cutoff value of -80, are connected by a line. In this network 
archaeal (red), bacterial (green) and eukaryotic (yellow) OMPDCs separate into distinct 
clusters.  
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Figure 3. Half-lives of biochemically important reactions proceeding spontaneously in 
water. The figure was reproduced with the permission of Lewis et al. (3) Copyright 
belongs to the National Academy of Sciences of USA. 
 
STRUCTURE OF OMPDC 
Several research groups have independently solved crystal structures of OMPDC 
orthologs, from various organisms (4-6). All of the structures have divergent sequence 
identity, with key active site residues that are highly conserved. The model OMPDC 
enzyme used in this work is from the thermophilic archaeon, Methanothermobacter 
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thermoautotrophicum (MtOMPDC). This enzyme has high stability, can be purified in 
relatively large quantities and can easily crystallize to form well-diffracting crystals. This 
later property of this ortholog makes structural interpretation of kinetic properties of 
mutant OMPDCs easy. To date, there are more than 70 structures of MtOMPDC mutants 
in various inhibitor bound and apo forms. 
 
     OMPDC has a triose phosphate isomerase (TIM) (β/α)8-barrel fold, a common 
structural architecture found in enzymes (Figure 4). Examination of the inhibitor-bound 
structure shows that the enzyme is a homodimer, forming a two-fold axis of symmetry. 
Each monomer contains an active site located at the mouth of each (β/α)8-barrel. Each 
active site consists of residues donated by both symmetry related monomer, making 
OMPDC an obligate dimer. 
 
     The active site of OMPDC contains a highly conserved DXKXXD motif consisting of 
Asp70, Lys72 and Asp75*(*from symmetry related polypeptide) (Figure 5). This motif, 
along with Lys42 and Asp20, form a charged network. Asp70 has been implicated in 
ground-state destabilization (GSD) and Lys72 is the active site acid that protonates the 
vinyl carbanion intermediate after the departure of the carboxylate moiety (vide infra). 
Hence this motif is sometimes referred as the catalytic motif. 
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Figure 4. Structure of MtOMPDC bound to BMP (PDB ID: 3LTP). Protein is shown in 
cartoon representation and ligand BMP is shown in space-filling representation. 
      
 
     Apart from the catalytic motif, the active site of OMPDC contains several conserved 
interactions with the pyridine base and the phosphoribosyl moiety. Among these is 
Ser127 whose side-chain makes important contact with N-3 of the pyrimidine base and 
side-chain of Gln185; Gln185 also makes hydrogen-bonding interactions with O2 of the 
pyrimidine ring and the phosphate group of the phosphoribosyl moiety, “tethering”, so 
to say, different parts of the enzyme and substrate together into a precise geometry 
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(Figure 5). Gln185 is a part of a flexible loop that is disordered in the apo structure 
and is ordered in the inhibitor/substrate bound structure, completely occluding the 
active site from solvent. Arg203 and Gly203 also make important contacts with the 
phosphate group. Apart form the residues that directly interact with the phosphate 
group; other residues in the active site indirectly interact with the phosphate group via 
ordered water molecules, forming an intricate network of interactions (not shown). 
 
Figure 5. Important active site interactions in OMPDC. The figure was generated using 
PDB coordinates of MtOMPDC bound to BMP (PDB ID: 3LTP). 
 
 
 
!
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MECHANISM OF OMPDC 
Prior to the availability of crystal structures, several mechanisms had been proposed for 
OMP decarboxylase catalyzed reaction (Figure 6); most of these mechanisms were 
incompatible with the solved structures of OMPDC due to absence of appropriate 
functional groups in the enzyme active site (1, 4, 7-10). The established mechanism 
consistent with the crystal structures and kinetic studies is a two-step mechanism 
consisting of formation of a vinyl carbanion intermediate and subsequent protonation 
(Figure 7). Earlier studies of comparing C-13 isotope effects of OMP vs 5-fluoro OMP 
(FOMP) by Van vleet et al. found ~1.5% decrease in isotope effect implying a stabilizing 
effect of carbanion intermediate by the inductive 5’-fluoro substituent of FOMP and 
thereby, indirectly showing importance of a carbanion intermediate (9). More direct 
evidence of the two-step carbanion mechanism came from work by Toth et al., which 
showed that OMPDC catalyzed the H/D exchange (50%) of H6 of UMP in 50/50 
H2O/D2O solution (10, 11). 
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Figure 6. Proposed mechanisms for OMP decarboxylase reaction. This figure was 
reproduced with permission of Houk et al. (8) Copyright to this figure belongs to J. 
Phys. Chem. B. 
 
 
 
     Lee et al. proposed a carbene based transition state based on quantum mechanical 
calculations (7). This mechanism proposes a stabilization of the transition state by 
formation of resonance structure of vinyl carbanion where the negative charge resides 
 
 
10 
on O4 of the intermediate, which can then be stabilized by protonation at O4. Although 
the crystal structure of OMPDC (solved after the proposed mechanism) does not contain 
any proton donor near O4 of the pyrimidine base, the possibility of a carbene resonance 
form, stabilized by an enhanced hydrogen bond (short-strong hydrogen bond) with the 
backbone amide nitrogen of conserved active site Ser127, cannot be ruled out. Indirect 
support for the importance of such a resonance form comes form the discovery of the 
potent inhibitor 6-hydroxy UMP (BMP) (picomolar Ki), a putative transition-state analog 
for OMPDC catalyzed reaction (Figure 7) (12). Chapter 2 investigates this possibility by 
mutating of the backbone amide bond to ester bond and kinetically characterization of 
this mutant. 
 
Figure 7. (A) Two-step mechanism of OMPDC catalyzed reaction showing vinyl and 
carbene intermediates. (B) Resonance forms of transition state analog BMP at pH 7. 
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ROLE OF GROUND-STATE DESTABILIZATION 
After the first crystal structure of OMPDC bound to BMP was solved, it became apparent 
that OMP in the active site of the enzyme could experience electrostatic stress from the 
nearby negative charge of Asp70 (13). If this is true, ground-state destabilization of 
substrate carboxylate group can facilitate its departure and contribute to the 1017 fold 
rate enhancement. For some time, the existence of ground-state destabilization in 
OMPDC catalysis had been a subject of controversy. Molecular dynamic studies by 
Warshel et al. posit that only transition-state stabilization is important for OMPDC 
catalysis, as the charged preorganization of the active site reduces the protein-protein 
reorganization energy (14). In contrast, work done in our lab by Chan et al. showed 
that the D70N mutant has a reduced kcat compared to wild-type enzyme for FOMP 
decarboxylation but has an unchanged rate of H/D exchange reaction of FUMP H-6 in 
deuterated solvent (15). This shows the possible role of Asp70 in ground state 
destabilization. Iams et al. showed the role of a hydrophobic pocket proximal to the 
orotate-binding site, formed by Ile96, Leu123, Val155, and Pro180, in accentuating the 
stress experienced by the carboxylate moiety (16). It was proposed that that OMP 
interacts with the enzyme using favorable binding energy of various active site 
interactions, remote from the carboxylate moiety. This juxtaposes the carboxylate 
moiety next to the unfavorable interactions of Asp70 and the hydrophobic pocket, 
facilitating its departure. This phenomenon, called the “Circe effect”, where the binding 
energy of a remote substituent “pays” for unfavorable interaction at the site of 
chemistry, to facilitate catalysis, was first proposed by Jencks (17). More recent work by 
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Fujihashi et al. shows the presence of significant stress in crystal structure of MtOMPDC 
bound to various analogs of UMP with different C-6 substituent groups, supporting the 
presence of ground-state destabilization. They show that Lys72 is responsible for steric 
stress which is relieved upon decarboxylation (18, 19). 
 
ROLE OF 5’-PHOSPHATE MOIETY OF OMP 
The 5’-phosphate group of OMP is spatially remote from the carboxylate moiety. Yet it 
has been shown to be very important in OMPDC catalyzed reaction. The second order 
rate constants for a truncated substrate devoid of the 5’-phosphate group decreases by 
a factor of 2.5 X 108 (Figure 8) (20-23). This is the largest known effect of a remote 
substituent, not partaking in chemical transformation on enzyme-catalyzed rates. The 
5’-phosphate moiety makes several contacts with active site residues including, but not 
limited to, side chains of Gln185 and Arg203 and backbone of Gly202. Together they 
form a network of interactions in the substrate/inhibitor-bound form of the enzyme. The 
importance of these interactions in OMPDC catalysis has not been well characterized 
and is one the main topics of inquiry in Chapter 3. 
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Figure 8. MtOMPDC catalyzed second order rates for decarboxylation of OMP and 
truncated substrate having no 5’-phosphate group (EO).  
 
 
CONFORMATIONAL CHANGES IN OMPDC 
Comparison of the apo form of the enzyme with the BMP bound form shows several 
changes in the organization of the enzyme. The most important is organization of the 
active site loop. Work in our lab by Wood et al. showed that ordering of the active site 
loop is facilitated by formation of a hydrophobic cluster consisting of Val182, Ile199, 
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Val201 and Ile218 (Figure 9). Alanine mutants of these hydrophobic residues show an 
increase in KM, with little change in kcat. It was proposed that these residues stabilize 
the closed conformation of the enzyme (24). 
 
Figure 9. Superposition of MtOMPDC apo structure (PDB ID: 1LOR) with BMP bound 
structure (PDB ID: 3LTP). Only the monomer is shows for easy visualization. 
 
     Larsen et al., using HINGEFIND algorithm, classified the OMDPC architecture into 
two domains based on their flexibility: a) the rigid core domain consisting of two half 
(β/α)8-barrels associated with each other by the dimer interface; and b) the relatively 
flexible, mobile domain (25). Comparison of the apo and BMP bound structures of 
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MtOMPDC shows several hydrogen bonding interactions that occur at the interface of 
the two domains in the BMP bound structure (T159, R160 and Y206) (Figure 9). The 
detailed importance of these interactions is studied in Chapter 3. Moreover, the 
relationship between substrate binding via the phosphate moiety and remote 
conformational changes is also investigated. 
 
     Finally, the principles that are learned from OMPDC catalysis are applied in Chapter 
4, where the possibility of FrsA, a protein belonging to α/β hydrolase superfamily to 
catalyze cofactor-less decarboxylation of pyruvate, is investigated. Prior to our work, 
Lee et al. reported that this protein decarboxylates pyruvate in a cofactor independent 
manner similar to OMPDC (26). 
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CHAPTER 2: INVESTIGATING THE ROLE OF A BACKBONE TO SUBSTRATE HYDROGEN 
BOND IN OMP DECARBOXYLASE USING A SITE-SPECIFIC AMIDE TO ESTER 
SUBSTITUTION 
 
ABSTRACT: Hydrogen bonds between backbone amide groups of enzymes and their 
substrates are often observed, but their importance in substrate binding and/or 
catalysis is not easy to investigate experimentally. We describe the generation and 
kinetic characterization of a backbone amide to ester substitution in the orotidine 5′-
monophosphate (OMP) decarboxylase from Methanobacter thermoautotrophicum 
(MtOMPDC) to determine the importance of a backbone amide–substrate hydrogen 
bond. The MtOMPDC-catalyzed reaction is characterized by a rate enhancement (∼1017) 
that is among the largest for enzyme-catalyzed reactions. The reaction proceeds 
through a vinyl anion intermediate that may be stabilized by hydrogen bonding 
interaction between the backbone amide of a conserved active site serine residue (Ser-
127) and oxygen (O4) of the pyrimidine moiety and/or electrostatic interactions with 
the conserved general acidic lysine (Lys-72). In vitro translation in conjunction with 
amber suppression using an orthogonal amber tRNA charged with L-glycerate (HOS) was 
used to generate the ester backbone substitution (S127HOS).  
 
 
Reprinted (adapted) with permission of Desai, B. J.; Goto, Y.; Cembran, A.; Fedorov, A. A.; Almo, S. C.; Gao, J.; 
Suga, H.; and Gerlt, J. Proc Nat Acad Sci USA 2014, 42, 15066-15077. DOI: 10.1073/pnas.1411772111. Copyright 
belongs to the authors. 
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We conclude that (i) the hydrogen bond between the backbone amide of Ser-127 and 
O4 of the pyrimidine moiety contributes a modest factor (∼102) to the 1017 rate 
enhancement and (ii) the stabilization of the anionic intermediate is accomplished by 
electrostatic interactions, including its proximity of Lys-72. These conclusions are in 
good agreement with predictions obtained from hybrid quantum mechanical/molecular 
mechanical calculations. 
 
INTRODUCTION 
Elucidation of the structural strategies by which enzymes achieve their large rate 
enhancements is essential for understanding the evolution of enzymatic catalysis as well 
as facilitating the design of enzymes to catalyze novel reactions. Typically, the possible 
strategies are identified by high-resolution X-ray structural analyses, in which a stable 
mimic of a reactive intermediate or rate-determining transition state is bound in the 
active site. Then, site-directed mutagenesis is used to generate substitutions, in which 
the important interactions are removed or altered, with kinetic analyses and structural 
studies of the mutant enzymes allowing the importance of the interaction to be 
assessed. Indeed, for nearly 30 y, this approach has been used to evaluate the 
importance of interactions involving amino acid side chains. However, structural studies 
of many enzymes reveal the presence of hydrogen-bonding interactions between a 
backbone amide group donor and a heteroatom acceptor in the substrate. Such an 
interaction can contribute to catalysis by increasing in strength as the basicity/proton 
affinity of the acceptor is increased as the reaction coordinate is traversed (1). Perhaps 
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the best known example of such an interaction is the oxyanion hole in serine proteases, 
in which the substrate peptide carbonyl group is converted to an anionic tetrahedral 
intermediate (2). However, the importance of the presumed enhanced hydrogen-
bonding interaction between the oxyanion hole and the substrate/intermediate has not 
been directly evaluated because of the difficulty in mutating the backbone amide group 
donor and/or the substrate acceptor. OMP decarboxylase (OMPDC) provides another 
important example of a hydrogen bonding interaction between a backbone amide group 
and a hydrogen bond acceptor in the substrate that has been proposed to be important 
for stabilizing a reactive intermediate. OMPDC is a paradigm for understanding the 
structural features responsible for catalytic efficiencies of enzymes, because the 
reaction is cofactor-independent; also, the rate enhancement (∼1017) and proficiency 
(affinity for the transition state; ∼1023 M) are among the largest for any enzyme-
catalyzed reaction (3). The rate enhancement is a composite of substrate destabilization 
and intermediate stabilization (Figure 10A) (4–11). The pKa of the UMP product is 
reduced from 30 to 34 in solution to ≤22 in the active site, requiring significant 
stabilization of the vinyl anion intermediate (∼14 kcal/mol) (12–14). 
 
     Others and we have characterized structure–function relationships in the OMPDC 
from Methanobacter thermoautotrophicum (MtOMPDC). The structure of MtOMPDC with 
the potent competitive inhibitor 6-hydroxyuridine 5′-monophosphate [BMP; also known 
as 1-(5′-phospho-β-D-ribofuranosyl)barbiturate] reveals (i) a hydrogen bonding 
interaction between the backbone amide group of Ser-127 and O4 of the pyrimidine 
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moiety and (ii) the proximity of carbon-6 to the ε-ammonium group of Lys-72, the 
general acidic catalyst. Accordingly, two structural strategies have been proposed for 
stabilization of the anionic intermediate (Figure 10B): (i) an enhanced hydrogen-
bonding interaction between the Ser-127 backbone amide and O4 of the pyrimidine 
moiety of the intermediate through a carbene resonance structure (anionic charge on 
O4) (8, 11, 15) and (ii) electrostatic interactions between the anionic charge on carbon-
6 with the e-ammonium group of Lys-72 (4, 9). Both are challenging to test: (i) 
substitutions for backbone amide groups are difficult to construct, and (ii) Lys-72 is the 
essential general acid catalyst. We constructed the S127P mutant to evaluate the 
importance of the interaction of the backbone amide group with O4; the mutant has a 
dramatically reduced value for kcat/KM (106-fold) compared with WT MtOMPDC. 
However, a comparison of liganded X-ray structures of the WT and S127P mutant 
revealed a displacement of BMP in the active site as the result of the steric interactions 
between the proline side chain and O4, thereby making interpretation of the importance 
of the interaction of the backbone amide group with O4 difficult (8). We now report 
kinetic constants for the variant of MtOMPDC in which the backbone amide group of 
Ser-127 is replaced with an ester group. The Ser to L-glycerate (HOS) substitution 
(S127HOS) eliminates the backbone hydrogen bond while keeping the interaction of the 
side chain hydroxyl group with N3 of the orotate moiety intact. However, the 
substitution juxtaposes the backbone ester oxygen with O4, having the potential to 
reduce the affinity for the substrate and/or destabilize the carbene-like resonance 
structure of the anionic intermediate. Using 5-fluoroOMP (FOMP) as the substrate, we 
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found that the value of kcat is reduced ≤50-fold and that the value of KM is increased 
≤1.5-fold relative to WT MtOMPDC. We conclude that the hydrogen bond between the 
backbone amide and O4 contributes a factor of ≤102 to the 1017 rate enhancement, 
suggesting that the anionic intermediate is stabilized primarily by electrostatic 
interactions within the active site, including Lys-72. These conclusions are in good 
agreement with predictions obtained from hybrid quantum mechanical/molecular 
mechanical calculations. They also illustrate the considerable power of combining a 
variety of biochemical and biophysical approaches (experimental enzymology, in vitro 
translation, crystallography, and computation) to tackle a challenging biochemical 
problem and the importance of the interactions of backbone amide groups of enzymes 
with substrates to stabilize reactive intermediates and transition states. 
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Figure 10. (A) Reaction catalyzed by OMPDC.  (B) Active site of MtOMPDC with 6-OH 
uridine 5’-monophosphate (BMP), a vinyl anion intermediate analog.  The figure was 
generated using coordinates from PDB ID 3LTP using Chimera  (42).  
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RESULTS 
In Vitro Protein Synthesis. We used the H128N mutant of MtOMPDC to eliminate the 
possibility of general base-catalyzed hydrolysis of the backbone ester bond by the 
spatially proximal imidazolium group of His-128. The kinetic constants for H128N are 
identical to those for WT enzyme; no structural perturbation is observed in the X-ray 
structure (Appendix A, Figure 27 and Table 6). In our experiments, we used the 
PURExpress In Vitro Translation Kit prepared from purified components from 
Escherichia coli (New England Biolabs). A yield of 0.22 mg/mL H128N was achieved by 
(i) using a synthetic gene optimized for codon use for E. coli and a low probability of 
forming secondary structures in the mRNA transcript (Genscript), (ii) optimizing the 
spacing between the ribosome binding site and the initiation codon, (iii) deleting the N-
terminal 11 amino acids that are disordered in X-ray structure, and (iv) optimizing the 
amount of plasmid. The flexible tRNA acylation ribozyme system was used to acylate an 
orthogonal amber suppressor tRNA with the 3,5-dinitrobenzyl ester of HOS or Ser; 
acylation yields were ∼40% (16–18) (Appendix A). Using suppressor tRNA charged 
with either HOS or Ser, full-length proteins with easily measurable activities were 
produced by in vitro translation of the template with the amber codon (TAG) replacing 
the WT codon for Ser (AGC; see below) (Figure 11A). In the absence of suppressor 
tRNA, a full-length protein with negligible activity (Appendix A, Figure 28 reaction b, 
and Table 7) was produced as the result of adventitious suppression of the amber 
codon by glutamine (encoded by the CAG/CAA codon; S127Q; see below). 
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In all reactions, small quantities of the N-terminal residue 12– 126 peptide were formed 
(Figure 11A); this early termination may be explained by the incomplete acylation of 
the suppressor tRNA. 
 
     To verify that S127HOS is produced with suppressor tRNA charged with HOS, 
reactions were incubated at pH 10 and 70 °C for 1 h to cleave the ester backbone 
(Figure 11B). The amount of full-length protein obtained with suppressor tRNA 
charged with Ser in the absence of suppressor tRNA was modestly decreased. In 
contrast, the  
 
 
Figure 11. Autoradiograph of an SDS-PAGE gel of the in vitro translation reactions 
containing the S127amber/H128N plasmid with amber suppressor tRNA charged with 
L-serine (S); L-glycerate (HOS); no amber tRNA (-).  Panel A, no alkali or heat treatment 
prior to SDS-PAGE experiment.  Panel B, reactions incubated at pH 10 and 70 °C for 1-
hour prior to SDS-PAGE experiment.  The expected protein fragments are marked on 
the right. 
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amount of full-length protein obtained with suppressor tRNA charged with HOS was 
significantly decreased; the bands corresponding to the N-terminal residue 12–126 and 
the C-terminal residue 127–228 peptides of the full-length protein were produced in the 
expected 2:1 ratio (4 and 2 Met residues, respectively), confirming the presence of the 
backbone ester. The reaction components precipitate under these conditions, and 
therefore, enzymatic activities could not be used to verify the expected loss of activity 
for the S127HOS substitution (activity was lost for the protein produced when the 
suppressor tRNA was charged with either HOS or Ser). 
 
MS Analysis of in Vitro-Synthesized Proteins. MS/MS analysis of SDS/PAGE-
purified and Glu-C endopeptidase-digested in vitro expressed WT (H128N) identified a 
peptide with a mass of 1,422.64 Da in high abundance, corresponding to 
VFLLTEMoxSNPGAE (Mox is oxidized Met; residues 120–132) (Figure 12A). A similar 
analysis of S127HOS identified a peptide with a mass of 1,423.66 Da in high abundance, 
corresponding to VFLLTEMox(S→HOS)NPGAE (residues 120–132) (Figure 12B). The 1-
Da difference in the masses of the peptide fragments from WT and S127HOS is equal to 
the difference in the masses of serine and glycerate. In addition, the peptide fragment 
corresponding to MoxSNPGAEMoxFIQGAADE (residues 126–141) was detected in high 
abundance in the WT protein (Appendix A, Figure 29A). An analogous peptide was 
detected in S127HOS, (S→HOS)NPGAEMoxFIQGAADE, except that it lacks Met-126 
(Appendix A, Figure 29B). This fragment is not the product of Glu-C hydrolysis (Glu-
C cleaves after glutamate or aspartate residues) and presumably, is formed by 
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hydrolysis of the labile ester bond between Met-126 and HOS 127 during gel 
staining/destaining process and before performing the MS analysis. Thus, the detection 
of this fragment provides strong evidence for the incorporation of HOS at residue 127. 
The amino acid incorporated in the absence of suppressor tRNA was identified as 
glutamine (i.e., S127Q) (Appendix A, Figure 30). Analysis of the protein produced in 
the Ser-suppressed control showed the presence of peptides containing both Ser and 
Gln at the 127th position (WT and S127Q) (Appendix A, Figure 31). Analysis of the 
HOS-suppressed control detected the presence of only HOS at the 127th position, 
suggesting the production of a negligible amount of S127Q when the HOS-charged 
suppressor tRNA was used. This conclusion is also supported by the nearly complete 
hydrolysis of the full-length S127HOS protein (Figure 11), suggesting that the majority 
of the protein produced in the presence of suppressor tRNA charged with L-glycerate 
contains an alkali–labile ester linkage. 
 
Kinetic Analysis of in vitro-Synthesized Proteins. The in vitro translation reactions 
were assayed using FOMP, because it is ∼500-fold more reactive than OMP due to the 
electron-withdrawing substituent that stabilizes the anionic intermediate (19). In this 
way, the values of kcat, KM, and kcat/KM could be determined by following 
the reactions to completion for the in vitro-expressed WT (H128N), WT (H128N) 
expressed in the Ser-suppressed reaction, and S127HOS. The kinetic constants are 
displayed in Table 1. WT (H128N) produced by in vitro translation using a plasmid 
template with the Ser codon has values of kcat and KM similar to those for the WT 
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(H128N) expressed in and purified from E. coli, confirming the integrity of in vitro-
produced enzyme. The protein produced in the absence of a charged suppressor tRNA 
(S127Q; see above), the expected contaminant in reactions using suppressor tRNA 
charged with Ser or HOS, represents the upper limit of contaminating activity present in 
proteins produced by amber suppression using amber tRNA; this activity is negligible 
(Appendix A, Figure 28 reaction b and Table 7). This control rules out the possibility 
that the activity measured for either the WT protein produced by suppression with Ser 
or S127HOS produced by suppression with HOS is the result of a catalytically active 
contaminant produced by the components of the in vitro translation reaction. 
 
     Furthermore, as described above, we observed that Gln is incorporated in the 
absence of suppressor tRNA. This incorporation is easily explained: the amber codon is 
TAG, and the codons for Gln are CAG/CAA. We prepared the S127Q mutant from a 
strain of E. coli in which the gene encoding OMPDC is disrupted: the value of kcat/KM for 
the S127Q is 2.4 X 102 M−1 s−1, significantly lower than those measured for the proteins 
produced by suppressor tRNA charged with either HOS (S127HOS) or Ser (Appendix A, 
Table 8). The value of kcat for WT (H128N) produced using suppressor tRNA charged 
with Ser is twofold less than that measured for WT (H128N) produced using a plasmid 
template with the Ser codon; this decrease can be explained by the presence of the 
adventitious, catalytically inactive S127Qdetected in our MS analysis (Appendix A, 
Figure 31). The value of kcat for S127HOS produced using suppressor tRNA charged 
with HOS (6.7 s−1) is reduced 50-fold from WT (H128N) produced using a plasmid 
 
 
31 
template with the Ser codon and 25-fold from the WT (H128N) produced using 
suppressor tRNA charged with Ser (Table 1). Our MS analysis of S127HOS did not 
detect S127Q, and therefore, the upper limit on the reduction in activity associated with 
the amide to ester substitution is 50-fold; assuming that S127HOS contains the same 
amount of S127Q as the WT control, the reduction in activity is 25-fold. Irrespective, we 
conclude that the activity of S127HOS is significant and associated with the amide to 
ester substitution. The value of KM for S127HOS (140 µM) is elevated threefold from 
that measured for WT (H128N) produced using a plasmid template with the Ser codon 
and identical, within error, to that measured for WT produced using suppressor tRNA 
charged with Ser. We conclude that binding of the substrate is not significantly 
perturbed by backbone ester–O4 interaction that results from the amide to ester 
substitution. 
Table 1.  Kinetic constants for FOMP decarboxylation, measured at 25°C and pH 7.1. 
 kcat 
(s-1) 
KM 
(mM) 
kcat/KM 
(s-1 M-1) 
H128Na  340 ± 40 90 ± 10 (3.8 ± 0.6) x 106 
H128Nb 280 ± 20 52 ± 4 (5.4 ± 0.6) x 106 
H128Nc 140 ± 40 120 ± 20 (1.2 ± 0.4) x 106 
S127HOSc 6.7 ± 1.9 140 ± 20 (4.8 ± 1.5) x 104 
 
a, purified from E. coli; b, in vitro translation using wild type plasmid; c, in vitro 
translation using amber suppression. 
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Figure 12. MS/MS analysis of in vitro-synthesized WT (H128N) and S127HOS proteins. 
(A) MS/MS fragmentation of the parent ion from the WT protein corresponding to the 
sequence VFLLTEMoxSNPGAE (residues 120–132). (B) MS/MS fragmentation of the 
parent ion from the S127HOS protein corresponding to the sequence 
VFLLTEMox(S→HOS)NPGAE (residues 120–132). The observed [Mr (obs)] and calculated 
[Mr (calc)] monoisotopic masses of the parent ions are indicated on each spectrum. 
Assigned b- and y-fragment ions are numbered according to the modified Roepstorff 
and Fohlman nomenclature (31, 32).  
Parent ion: VFLLTEMoxSNPGAE; Mr (obs)1422.64; Mr (calc)1422.67   
 
Parent ion: VFLLTEMox(S!HOS)NPGAE; Mr (obs)1423.66; Mr (calc)1423.65   
 
m/z 
A 
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Hybrid Quantum Mechanical and Molecular Mechanical Studies. We carried out 
molecular dynamics simulations using a combined quantum mechanical and molecular 
mechanical (QM/MM) potential to dissect the effects of the backbone ester substitution 
on catalysis. The approach has been validated previously and applied to the WT 
MtOMPDC (5). The free energy profiles for WT and S127HOS mutant are depicted in 
Figure 13A. The free energy barrier was calculated to be 4.3 kcal/mol greater for 
S127HOS than for the WT enzyme. The charge distribution of the carbanion intermediate 
of the decarboxylation reaction is highly delocalized over the entire pyrimidine ring in 
the active site of OMPDC, with an average partial atomic charge of only −0.22 a.u. on 
the C6 position from Mulliken population analysis as well as electrostatic potential fitting 
(Appendix A, Tables 9 and 10). The remaining charge density is distributed to the 
C5H and C4O4 groups, with net charges of −0.36 and −0.26 a.u., respectively, and the 
rest is distributed to the nitrogen sites. Although this seems to be consistent with a 
carbene-like structure at the C6 position, its relatively small net charge is a result of 
combined effects of π-conjugation and σ-delocalization (evidenced by the negative 
charge at C5). In contrast, the anionic charge is primarily localized on the carboxylate 
group of OMP in the Michaelis complex state. Thus, the relief of electrostatic stress of 
the charge-localized reactant state, caused by interaction with the Asp residue in the 
active site, provides a significant contribution to the rate acceleration. The 
S127HOS substitution has the largest effects on the carbanion intermediate, with a net 
electron density shift of 0.03 a.u. from the O4 carbonyl oxygen to the C6 atom through 
π-conjugation compared with the WT OMPDC. We attribute this charge shift to the 
 
 
34 
negative impact of the lone pair electron density of the ester oxygen in the S127HOS 
mutant. Nevertheless, the effect of the backbone mutation on the charge redistribution 
of the pyrimidine ring is relatively small, consistent with the observation that rate 
reduction is modest. The S127HOS substitution induces significant distortion of the active 
site at the transition state (Figure 13B). In WT, the O4 oxygen of the orotate moiety 
of the substrate is hydrogen-bonded to the Ser-127 backbone amide, with an average 
donor–acceptor distance of 3.0 Å. However, the amide to ester substitution introduces 
an electrostatic clash with the O4, elongating the distance between O4 and the ester 
oxygen by 0.5 Å to an average of 3.5 Å (Figure 13B and Appendix A, Figure 32). 
We performed interaction energy decomposition analysis between the orotate moiety 
and residue 127 to estimate the energetic consequence as a result of the Ser to HOS 
backbone substitution (Appendix A, Table 11). In WT, the Ser-127 backbone amide 
contributes 1.9 kcal/mol to transition state stabilization relative to that of the Michaelis 
complex. However, in S127HOS, the interaction between orotate and the HOS backbone 
ester group results in a destabilizing effect of 1.4 kcal/mol in going from the reactant 
state to the transition state as the anionic charge is shifted from the carboxylate group 
into the pyrimidine ring. Therefore, in the WT enzyme, this charge redistribution is 
stabilized by the Ser-127 backbone amide hydrogen bond, whereas in S127HOS, its 
formation is penalized by interactions with the ester oxygen atom lone pairs.  
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Discussion 
We have successfully used in vitro translation to produce sufficient quantities of the 
S127HOS substitution of MtOMPDC to allow experimental assessment of the importance 
of the hydrogen bond between the backbone amide group of Ser-127 and O4 of the 
pyrimidine moiety of the substrate. Interpretation of the experimental results together 
with parallel computational predictions of the effects of the substitution on the reaction 
coordinate allow important conclusions about the structural strategies for stabilization of 
the anionic intermediate. The values of both kcat and kcat/KM for WT MtOMPDC are 
partially diffusion-controlled (i.e., the transition states for substrate binding and product 
dissociation are similar in energy to that for decarboxylation). As a result, the value of 
kcat underestimates the rate constant for decarboxylation of the WT•FOMP complex. 
Based on both the fractional inverse dependence of kcat on solvent viscosity (slope = 
0.6) and a comparison of the values of kcat for both FOMP and OMP for the D70N 
mutant, where chemistry is rate-determining, we estimate that the rate constant for 
decarboxylation for the WT•FOMP complex is ∼1,000 s−1 (19). Therefore, the ester 
substitution reduces the rate of decarboxylation of the S127HOS•FOMP complex ∼150-
fold. This rate reduction corresponds to an increase of ∼3 kcal/mol in the activation 
energy barrier, which is in good agreement with the computed increase of 4.3 kcal/mol 
in the free energy barrier for S127HOS relative to the WT enzyme. In contrast, the value 
of KM is increased by only twofold, suggesting that the juxtaposition of O4 with the ester 
bond does not significantly interfere with the binding of FOMP. 
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     Our kinetic data and calculations together establish that stabilization of the vinyl 
anion intermediate is decreased ∼3 kcal/mol by a combined effect of loosening the 
hydrogen-bonding interaction of O4 with the Ser-127 backbone amide and juxtaposing 
the O4 and ester functional groups. Interaction energy decomposition analysis shows 
that, of the ∼3-kcal/mol overall increase in the activation barrier because of the 
S127HOS substitution, <2 kcal/mol may be attributed to the stabilizing effects of the 
hydrogen bond between O4 and the Ser-127 amide group. This energy change 
represents only a small contribution to the overall catalytic effect that lowers the free 
energy barrier of the uncatalyzed process in water by 23 kcal/mol. Because 
development of the O4 anion resonance structure is essential for stabilization of a 
carbene-like intermediate, the relatively small stabilization effects by the Ser-127 
backbone amide suggest that it is unlikely to be a major resonance form for the 
decarboxylation intermediate. Therefore, in the context of the 1017 rate enhancement 
(23-kcal/mol decrease in ΔG‡), the interaction between the backbone amide and O4 
provides one of several modest contributions; others include substrate destabilization 
by enforced proximity of the substrate carboxylate group to Asp-70 in an otherwise 
hydrophobic pocket (5, 8). 
 
     We conclude that the dramatically reduced value for kcat/KM (106-fold) observed for 
the S127P mutant (8) is dominated by altered binding of the substrate/transition 
state/intermediate to the active site, resulting in suboptimal geometry for 
decarboxylation of the OMP substrate and/or protonation of the anion intermediate to 
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Figure 13. (A) Computed free energy profile for the decarboxylation reaction in wild 
type MtOMPDC and S127HOS. The reaction coordinate is defined by the C6-C6’ distance.  
(B) representative structures of the TS ensemble from the MD simulations for the wild-
type enzyme (backbone colored) and the S127HOS mutant (backbone in brown).  The 
QM region is shown as ball-and-stick. 
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yield the UMP product. Also, although electrostatic interactions between C6 of the 
intermediate and the ε-ammonium group of Lys-72, the general acid catalyst, have 
been proposed to be the major contributor to the ∼14-kcal/mol stabilization of the 
intermediate, the delocalized charge calculated for the intermediate suggests that this 
interaction is not the major contributor; instead, relief of the destabilizing interactions 
between the localized charge on the orotate carboxylate group with Asp-70 relative to 
the charge delocalized intermediate must be important for achieving the rate 
enhancement. In contrast to prior studies of MtOMPDC reported by these laboratories, 
in which X-ray structures were determined for all mutant proteins (a total of 75 Protein 
Data Bank depositions), we were unable to obtain sufficient amounts of S127HOS for 
structural characterization because of the costs associated with scaling up the in vitro 
translation reactions. However, the robust activity using FOMP provides compelling 
support for the validity of the experimental results and their interpretations. Finally, the 
success of these experiments shows that in vitro translation can be used to generate 
sufficient quantities of backbone amide to ester substitutions to test the importance of 
their interactions with substrates/intermediates/transition states interactions in other 
enzymes (e.g., serine proteases, haloalkane dehalogenases, and enoyl-CoA hydratase) 
(2, 20, 21). 
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Materials and Methods 
OMP and FOMP were prepared using previously published chemoenzymatic synthesis 
(4, 19, 22). Cell free protein synthesis kits, murine RNase inhibitor, T7 RNA polymerase, 
NTPs, Taq polymerase, and dNTPs were purchased from New England Biolabs.  
 
In Vitro Protein Synthesis. In vitro protein synthesis was performed using the 
PURExpress In Vitro Protein Synthesis Kit from New England Biolabs (23). Release 
factor-1 was omitted in all of the reactions unless stated otherwise (24, 25). Murine 
RNase inhibitor was added to all reactions at a concentration of 0.8 U/µL. The 
concentration of template plasmid used was 5 ng/µL. The MtOMPDC H128N plasmid 
was used for the synthesis of WT protein. MtOMPDC S127Amber/H128N plasmid was 
used for in vitro protein synthesis of the S127HOS. The flexible tRNA acylation ribozyme 
system was used to acylate an orthogonal amber suppressor tRNA with the 3,5-
dinitrobenzyl ester of HOS or Ser. Acylation yields were ∼40% (16, 17, 26) (Appendix 
A); 100 pmol amber suppressor tRNA charged with Ser or HOS was added per 1 µL in 
vitro protein synthesis reaction. After mixing the components, the reactions were 
incubated at 37 °C for 4 h. After 4 h, the reactions were brought to 4 °C by placing the 
tubes on ice. Radioisotope labeling of in vitro-synthesized proteins was achieved by 
adding [35S]-methionine at a final concentration of 10 nCi/µL.  
 
FOMP Decarboxylation Assay. The FOMP decarboxylation assays were performed 
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using a continuous UV spectrophotometric assay as previously described (18, 19, 27) 
with modifications. All assays were performed at 25 °C in 10 mM MOPS [3-(N-
morpholino)-propane sulfonic acid] buffer and 100 mM NaCl (pH 7.1) in a 1,000-µL 
quartz cuvette with a path length of 10 mm; a Cary Bio 300 spectrophotometer was 
used for all measurements. The concentration of the FOMP stock solution was 
determined by measuring absorbance at 270 nm of a known dilution in 0.1 M HCl using 
the molar extinction coefficient of FOMP (εFOMP = 9,895 M−1 cm−1). Concentrations of 
proteins purified from E. coli (MtOMPDC H128N and S127Q) were determined by 
measuring absorbance at 280 nm and 25 °C in 10 mM MOPS and 100 mM NaCl (pH 
7.1) using the molar extinction coefficient (ε280 = 5,960). Final enzyme concentrations 
of 30 nM and 3.5 µM were used for H128N and S127Q, respectively. The concentration 
of in vitro synthesized full-length protein was determined as described elsewhere 
(Appendix A). In vitro synthesized proteins were assayed by adding 5- or 10-µL 
aliquots of the in vitro reaction mixture in the assay, as is indicated in Appendix A, 
Table 7. The decay in absorbance corresponding to the disappearance of 
FOMP/formation of 5-fluoro uridine monophosphate was monitored at 300 nm 
(Appendix A, Figure 28). The value of kcat was determined using saturating 
concentrations of FOMP and measuring the initial rate of decarboxylation (Vo; 
corresponding to ≤5% reaction) using the rate of change in absorbance and Δε300 of 
−489 M−1 cm−1. This rate represents the Vmax. The kcat was calculated by dividing Vmax 
with the enzyme concentration determined previously; the value of KM was determined 
by following the first-order decay of decarboxylation at low FOMP concentrations (≤KM). 
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The decay curve was fit to a first-order decay function using nonlinear regression. The 
rate constant generated from this model represents Vmax/KM, from which the KM was 
calculated using the enzyme concentration and kcat determined previously. 
 
MS Analysis of in Vitro-Synthesized Proteins. Protein bands corresponding to full-
length OMPDC (Appendix A, Figure 33) were excised using a scalpel, placed in a 
clean Eppendorf tube, and stored at −20 °C. MS analysis was conducted using a 
Thermo LTQ Velos ETD Pro Mass Spectrometer. Before liquid chromatography MS/MS 
analysis, each protein band in its gel slice was crushed, destained, and dehydrated in 
50% (vol/vol) acetonitrile containing 25 mM ammonium acetate. Glu-C digestion was 
performed using Staph Protease–Sequencing Grade at 1:10 (Worthington Biochemical) 
using a CEM Discover Microwave Reactor for 15 min at 55 °C at 50 W. The digested 
peptides were extracted three times using 50% (vol/vol) acetonitrile containing 5% 
(vol/vol) formic acid, pooled, and dried using a Speedvac (Thermo Scientific). The dried 
peptides were suspended in 5% (vol/vol) acetonitrile containing 0.1% formic acid and 
applied to the liquid chromatography. Control and data acquisition of the mass 
spectrometer were done using Xcalibur 2.2 under the data-dependent acquisition mode; 
after an initial full scan, the top five most intense ions were subjected to MS/MS 
fragmentation by collision-induced dissociation. The raw data were processed by Mascot 
Distiller (Matrix Sciences) and then Mascot (version 2.4). The result was searched 
against the MtOMPDC H128N sequence and the National Center for Biotechnology 
Information NR Protein database. 
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Hybrid QM/MM Studies. Combined QM/MM molecular dynamics simulations were 
performed on an OMP–MtOMPDC complex constructed on the basis of the crystal 
structure of the BMP-bound complex (Protein Data Bank ID code 1LOR) following the 
procedure reported previously (5). The SQUANTUM implementation of the AM1 method 
(28) in CHARMM (29) (version c35a1) was used to model the QM region, which 
encompassed the entire orotate moiety. Additional details are provided in Appendix A. 
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CHAPTER 3: CONFORMATIONAL CHANGES IN OROTIDINE 5’-MONOPHOSPHATE 
DECARBOXYLASE:  A STRUCTURE-BASED EXPLANATION FOR HOW THE 5’-PHOSPHATE 
GROUP ACTIVATES THE ENZYME 
 
ABSTRACT:  The reaction catalyzed by orotidine 5’-monophosphate decarboxylase 
(OMPDC) continues to interest the mechanistic enzymology community because the 
structural strategy used to achieve the large values of its rate enhancement (kcat/knon = 
7.1 x 1016) and catalytic proficiency [(kcat/KM)/knon = 4.8 x 1022 M] remain poorly 
understood.  For all structurally characterized OMPDCs, the binding of a ligand 
(intermediate/transition state analog) is accompanied by a conformational change from 
an open, inactive conformation (Eo) that predominates in the absence of a ligand to a 
closed, active conformation (Ec) when the ligand is bound in the solvent-sequestered 
active site.  As the substrate is bound (initially as the Eo•S complex that undergoes a 
conformational change to the Ec•S complex) and traverses the reaction coordinate to 
form the stabilized vinyl carbanion/carbene intermediate, interactions are enforced that 
destabilize the carboxylate group of the substrate as well as stabilize the intermediate 
(in the Ec•S‡ complex).   
 
 
 
 
Reprinted (adapted) with permission of Desai, B. J.; Wood, B. M.; Fedorov, A. A.; Fedorov, E. V.; Goryanova, B.; 
Amyes, T. L.; Richard, J. P.; Almo, S. C.; Gerlt, J. A. Biochemistry 2012, 51, 8665-8678. DOI: 10.1021/bi301188k.  
Copyright 2014 American Chemical Society. 
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Focusing on the OMPDC from Methanothermobacter thermautotrophicus (MtOMPDC), 
the “remote” 5’-phosphate group of the substrate activates the enzyme 2.4 x 108-fold 
[comparing the values of kcat/KM for OMP and 1-(β-D-erythrofuranosyl)orotic acid (EO; 
the 5’-hydroxymethylphosphate truncated analog of OMP)]; the activation is 
equivalently described by an intrinsic binding energy (IBE) of 11.4 kcal/mol for the 
5’-phosphate group.  We studied the roles of residues in the activation that 1) directly 
contact the 5’-phosphate group (Gln 185 and Arg 203); 2) participate in a hydrophobic 
cluster near the base of the closed active site loop that sequesters the bound substrate 
from solvent (Val 182; “remote” from the 5’-phosphate group); and 3) form 
hydrogen-bonding interactions across the interface between the “mobile” and “fixed” 
half-barrel domains of the (β/α)8-barrel structure (Thr 159, Arg 160, and Tyr 206; also 
“remote” from the 5’-phosphate group).  Our structural and kinetic data support a 
structure-based model for the activation in which the IBE provided by the interaction of 
the 5’-phosphate group with its binding site is used, in part, to organize the active site 
loop and thereby enable interactions both near the N-terminus of the active site loop 
and across the domain interface that stabilize both the Ec•S and Ec•S‡ complexes 
relative to the Eo•S complex, thereby a reduction of 23 kcal/mol in the value of ΔG⧧.   
The conclusion that the IBE of the “remote” 5’-phosphate group provides stabilization of 
both the Ec•S and Ec•S‡ complexes, not just the Ec•S‡ complex, is central to 
understanding the structural origins of enzymatic catalysis as well as the requirements 
for the de novo design of enzymes that catalyze novel reactions. 
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INTRODUCTION  
Orotidine 5’-monophosphate decarboxylase (OMPDC;1 Scheme 1) that catalyzes the 
final step in pyrimidine biosynthesis is a remarkable catalyst:  the rate enhancement 
(kcat/knon = 7.1 x 1016) and the catalytic proficiency [(kcat/KM)/knon = 4.8 x 1022 M]; 
affinity for the transition state) are among the largest measured for enzyme-catalyzed 
reactions (2, 3).   
       
We, and others (4-7), have been interested in defining the strategies used by OMPDC 
to reduce the value of ΔG⧧ by 23 kcal/mol.  The reaction coordinate involves a vinyl 
carbanion/carbene intermediate that is stabilized by ≥14 kcal/mol by its interactions 
with the active site (8-10).   
MtOMPDC, like all OMPDCs, is an obligate dimer, with the active sites located at the 
dimer interface.  The interactions of conserved active site residues in the OMPDC from 
Methanothermobacter thermautotrophicus, MtOMPDC, the focus of this article, with 
BMP [l-(5-phospho-β-ribofuranosyl)barbituric acid], an intermediate/transition state 
analog (11), are shown in Figure 14.  Each active site contains an essential 
Asp-Lys-Asp motif involving Asp 70 and Lys 72 from one polypeptide and Asp 75* from 
the symmetry related polypeptide as well as hydrogen-bonding interactions between 
the pyrimidine ring and both the OH group and the backbone amide group of Ser 127. 
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Two structural strategies can be envisioned for destabilization of the OMP substrate as 
the transition state is formed:  1) electrostatic/steric destabilization of the carboxylate 
group by the proximal Asp (Asp 70) (12, 13); and 2) desolvation of the carboxylate  
group by a proximal hydrophobic cavity (formed by Ile 96, Leu 123, Val 155, and Pro 
180 (14, 15).  The importance of these interactions has been tested; each contributes 
~4 kcal/mol to the reduction in ΔG⧧.  
Figure 14. Active site of MtOMPDC showing the interactions of active site residues with 
BMP, an intermediate/transition state analog. 
 
     Also, at least two structural strategies can be envisioned for stabilization of the 
anionic intermediate as the transition state is formed:  1) attractive electrostatic 
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interactions with the ε-ammonium group of Lys 72 that protonates C6 of the 
intermediate (6); and 2) enhanced hydrogen-bonding interactions with the backbone 
amide group of Ser 127 (16, 17).  For the latter strategy to be effective, the negative 
charge must be delocalized to O4 in the pyrimidine ring (as described by the carbene 
resonance structure; Scheme 1); calculations support the participation of this 
interaction, although its importance has not been tested directly (16, 17).   
These destabilizing/stabilizing interactions are “enforced” by a closed, catalytically 
active conformation (Ec) that is observed crystallographically in the presence of the 
intermediate/transition state analogs 6-azaUMP (18) and BMP (11); in their absence, 
MtOMPDC exists in an open, catalytically inactive conformation (Eo) (Figure 15) (12, 
13).  The more favorable transition from Eo to Ec in the Eo•S and Ec•S complexes [Kc vs. 
Kc’ in the kinetic model shown in Scheme 2 and Figure 16 (19); vide infra] is 
responsible, in part, for a 2.4 x 108-fold activation of the enzyme and involves 1) 
closure of the nine-residue active site loop (Pro 180 to Asp 188) that sequesters the 
substrate from solvent, and 2) formation of a more compact conformation for the 
(β/α)8-barrel structure that juxtaposes the substrate with the residues involved in 
substrate destabilization and intermediate stabilization.      
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Figure 15. Superposition of the structures of individual polypeptides of unliganded (Eo) 
and BMP-liganded (Ec) MtOMPDC, showing the movement of the “mobile” domain (red 
a-helices and blue b-strands) toward the “fixed” domain (magenta a-helices and green 
b-strands).  The ordered active site loop is colored yellow in the BMP-liganded 
structure. 
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Each (β/α)8-barrel in the obligate dimer is formed from two “half-barrel” domains, a 
“fixed” domain (including β-strands 2, 3, 4, and 5) located at the dimer interface and a 
“mobile” domain (including β -strands 6, 7, 8, and 1) (20); in the transition from Eo and 
Ec, the “mobile” domain moves toward the “fixed” domain, constricting the active site 
cavity that envelops the substrate (Figure 2).2  Because the active site loop sequesters 
the substrate from solvent in the Ec•S complex, substrate binding to Eo must precede 
the conformational change.  Thus, “induced fit”, not “conformational selection”, is 
responsible for altering the distribution between Eo and Ec when the substrate binds 
(21).3 
The energy obtained from formation of the Eo•S complex from Eo + S is partitioned 
between 1) “gripping” the substrate [with the value of KM providing a measure of the 
affinity for the substrate (1/[Kc•Ks] in Scheme 2; Ks is defined as an association 
complex but KM is a dissociation constant)]; and 2) stabilizing both Ec•S and Ec•S‡ (vide 
infra) relative to Eo•S (Kc in Scheme 2).  That Ec is unstable relative to Eo in the 
absence of substrate (Kc’) facilitates release of the UMP product; if the total energy 
obtained from substrate binding were used only to “grip” the substrate, release of the 
product from the Ec•P complex likely would be rate-determining (22).  Therefore, the 
structural and energetic coupling between substrate binding to Eo and the subsequent 
transition from Eo•S to Ec•S is essential for understanding the catalytic strategy that 
produces the extraordinary rate enhancement.   
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 We recently reported initial efforts to identify structural features that stabilize 
Ec•S (19).  Those focused on a hydrophobic cluster that includes Val 182 in the active 
site loop as well as Ile 199, Val 201, and Ile 218 located near the C-terminal ends of the 
seventh and eighth β-strands in the “mobile” domain.  Substitutions of these residues 
that are “remote” from the binding site for the 5’-phosphate group with Ala increase the 
value of KM but have little effect on the value of kcat.  The simplest interpretation is that 
the hydrophobic cluster stabilizes the closed conformation of the active site loop and, 
therefore, contributes to the stability of Ec•S.   Without this stabilization, the formation 
of Ec•S from Eo + S is less favorable, requiring increased concentrations of substrate to 
provide the energy to enable its formation (as revealed by an increase in the value of 
KM).  However, when Ec•S is formed, it is fully competent to yield product via the vinyl 
anion/carbene intermediate and the transition state that precedes it on the reaction 
coordinate (Ec•S‡) so the value of kcat (the energy difference between Ec•S and Ec•S‡) is 
unchanged.   
In this article we focus on residues involved in hydrogen-bonding interactions between 
the “mobile” and “fixed” domains observed in Ec but not in Eo (involving Thr 159, Arg 
160, and Tyr 206), also “remote” from the binding site for the 5’-phosphate group, to 
determine whether these contribute to the stability of Ec•S.  We also target the only two 
residues (Gln 185 and Arg 203) that provide direct side chain contacts with the 
5’-phosphate group of the substrate and, therefore, reasonably would be involved in 
generation of the intrinsic binding energy (IBE) of the 5’-phosphate group that is used 
to enable stabilization of both Ec•S and Ec•S‡ relative to Eo + S (23).  Finally, we 
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examine double mutants involving one “remote” residue that contributes to the stability 
of Ec•S (Val 182, Thr 159, or Arg 160) and one residue that generates the IBE of the 
5’-phosphate group (Arg 203).  The kinetic and structural properties of the mutants are 
consistent with a structure-based model in which Ec•S and Ec•S‡ are stabilized equally 
relative to Eo•S by 1) the interaction of the 5’-phosphate group with its binding site that 
allows/directs reorganization of the active site loop, 2) assembly of the hydrophobic 
cluster near the N-terminus of the reorganized active site loop that stabilizes its closed 
conformation, and 3) formation of interactions across the domain interface in Ec•S and 
Ec•S‡, some of which (those involving Thr 159 and Arg 160) are spatially proximal to 
the reorganized active site loop and, therefore, are influenced by its structure.  This 
analysis clarifies the role of the IBE of the 5’-phosphate group in reducing the value of 
ΔG⧧ and provides the framework for a more detailed investigation of the structural 
features involved in both generation of the IBE and its use to facilitate the conversion of 
Eo•S to both Ec•S and Ec•S‡. 
The conclusion that the IBE generated by interaction of the 5’-phosphate group with its 
binding site allows stabilization of both the Ec•S and Ec•S‡ complexes, not just the Ec•S‡ 
complex, relative to Eo + S by enabling formation of “remote” interactions that stabilize 
Ec likely can be applied to many (all?) enzymes in which conformational changes 
accompany substrate binding.   
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MATERIALS AND METHODS 
 
Materials. OMP, EO , FEO, and BMP were prepared by published procedures (6, 11, 
13, 24-26).  All solutions were prepared with Millipore Ultrapure filtered water. 
Protein Expression and Purification and Site-Directed Mutagenesis.  The gene 
encoding MtOMPDC was previously cloned in the pET-15b vector (Novagen).  The 
site-mutants were constructed (overlap extension) and the wild type and mutant 
proteins were expressed and purified following previously published procedures (13, 15, 
24). 
Assay for Decarboxylation of OMP. Assays were performed at 25 °C and in 10 mM 
MOPS, pH 7.1, containing 100 mM NaCl following published procedures (13, 15, 24).    
Assay for Decarboxylation of EO.  The values of kcat/KM for decarboxylation of EO 
were determined as previously described (15, 25).  
 Assay for Decarboxylation of FEO.  For wild type MtOMPDC and single mutants, 
the values of kcat/KM for decarboxylation of FEO were determined by quantitating the 
first order decay of FEO at 290 nm using procedures developed for EO (15, 25).  
  For double and triple mutants, the values of kcat/KM for decarboxylation of FEO 
were determined using HPLC-based end point assays using procedures developed for 
EO (15, 25); the amount of FEU product was quantitated using 5-fluorouridine as the 
reference standard (ε = 9660 M-1 cm-1 in 0.1 N HCl). 
Crystallization and Data Collection. Eight different crystal forms (Table 2) were 
grown by the sitting drop method at room temperature for single mutants of MtOMPDC 
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liganded with BMP: (1) Q185A•BMP, (2) R203A•BMP, (3) T159V•BMP, (4) T159A•BMP, 
(5) T159S•BMP, (6) R160A•BMP, (7) Y206F•BMP, and (8) K82A•BMP.  The protein 
solutions for all eight crystallizations contained the corresponding protein (30 mg/mL) in 
20 mM HEPES, pH 7.5, 100 mM NaCl, 3 mM DTT, and 40 mM BMP.  The precipitants 
were the following:      
(1) For the Q185•BMP complex, the precipitant contained 30% PEG 4000, 0.1 M 
Tris•HCl, pH 8.5, and 0.2 M lithium sulfate. 
(2) For the R203A•BMP complex, the precipitant contained 2.4 M sodium malonate, 
pH 7.0. 
(3) For the T159V•BMP complex, the precipitant contained 30% PEG 4000, 0.1 M 
sodium citrate, pH 5.6, and 0.2 M ammonium sulfate.   
(4) For the T159A•BMP complex, the precipitant contained 20% PEG 4000, 20% 
2-propanol, and 0.1 M sodium citrate, pH 5.6.        
(5)  For the T159S•BMP complex, the precipitant contained 20% PEG 4000, 20% 
2-propanol, and 0.1 M sodium citrate, pH 5.6. 
(6)  For the R160A•BMP complex, the precipitant contained 30% PEG 4000, 0.1 M 
sodium citrate, pH 5.6, and 0.2 M ammonium acetate. 
(7) For the Y206F•BMP complex, the precipitant contained 30% PEG 4000, 0.1 M 
HEPES, pH 7.5, and 0.2 M magnesium chloride. 
(8)  For the K82A•BMP complex, the precipitant contained 20% PEG 8000, 0.1 M 
Tris•HCl, pH 8.5, and 0.2 M magnesium chloride. 
 
 
58 
 Ten different crystal forms (Table 3) were grown by sitting drop method at 
room temperature for double and triple mutants of MtOMPDC liganded with BMP: (1) 
Q185A•R203A•BMP, (2) T159V•V182A•BMP, (3) T159V•Y206F•BMP, (4) 
V182A•Y206F•BMP, (5) R160A•V182A•BMP, (6) R160A•Y206F•BMP, (7) 
R203A•V182A•BMP, (8) R203A•T159V•BMP, (9) R203A•R160A•BMP, and (10) 
T159V•V182A•Y206F•BMP. The protein solutions for all ten co-crystallizations contained 
the corresponding protein (30 mg/mL) in 20 mM HEPES, pH 7.5, 100 mM NaCl, 3 mM 
DTT, and 40 mM BMP.  The precipitants were the following: 
(1) For the Q185A•F203A•BMP complex, the precipitant contained 2.0 M ammonium 
sulfate, pH 4.9.  
(2) For the T159V•V182A•BMP complex, the precipitant contained 0.4 M sodium 
phosphate, 1.6 M potassium phosphate, 0.1 M imidazole, pH 8.0, and 0.2 M 
sodium chloride.  
(3) For the T159V•Y206F•BMP complex, the precipitant contained 1.4 M sodium 
citrate, and 0.1 M HEPES, pH 7.5.  
(4) For the V182A•Y206F•BMP complex, the precipitant contained 0.8 M sodium 
phosphate, 1.2M potassium phosphate, and 0.1 M acetate, pH 4.5. 
(5) For the R160A•V182A•BMP complex, the precipitant contained 30% PEG 4000, 
0.1 M Tris•HCl, pH 8.5, and 0.2 M lithium sulfate.  
(6) For the R160A•Y206F•BMP complex, the precipitant contained 30% PEG 4000, 
and 0.1 M Tris•HCl, pH 8.5, and 0.2 M magnesium chloride.  
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(7) For the R203A•V182A•BMP complex, the precipitant contained 1.0 M sodium 
citrate, and 0.1 M cacodylate, pH 6.5. 
(8)  For the R203A•T159V•BMP complex, the precipitant contained 0.8 M sodium 
phosphate, 1.2 M potassium phosphate, and 0.1 M acetate, pH 4.5. 
(9) For the R203A•R160A•BMP complex, the precipitant contained 3.5 M sodium 
formate, pH 7.0. 
(10) For the T159V•V182A•Y206F•BMP complex, the precipitant contained 
60% tacsimate, pH 7.0. 
 Prior to data collection, the crystals of all 18 crystal forms (Tables 2 and 3) 
were transferred to cryoprotectant solutions composed of their mother liquids and 20% 
glycerol and flash-cooled in a nitrogen stream.  The X-ray diffraction data sets (Tables 
2 and 3) were collected at the NSLS X4A beamline (Brookhaven National Laboratory) 
on an ADSC CCD detector and at NSLS X29A beamline on the 315q CCD detector. 
Diffraction intensities were integrated and scaled with programs DENZO and 
SCALEPACK (27). The data collection statistics are given in Tables 2 and 3 
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Table 2.  Data collection and refinement statistics for BMP complexes of single mutants  
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Table 3.  Data collection and refinement statistics for BMP complexes of double and 
triple mutants  
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Structure Determination and Model Refinement. All 18 MtOMPDC structures 
(Tables 2 and 3) were solved by molecular replacement with fully automated 
molecular replacement pipeline BALBES (28), using only input diffraction and sequence 
data.  Partially refined structures of all 18 MtOMPDC crystal forms (Tables 2 and 3) 
were the outputs from BALBES.  Subsequent several iterative cycles of refinement were 
performed for each crystal form including: model rebuilding with COOT (29), refinement 
with PHENIX (30), and automatic model rebuilding with ARP (31).  
 All loops are well-defined in all 18 BMP liganded MtOMPDC structures. Usually 
some loops are disordered in unliganded MtOMPDC structures. All 18 MtOMPDC 
complexes have well-ordered density for all bound BMP ligands in every active site. No 
nonglycine residue lies in disallowed regions of the Ramachandran plot for all 18 
MtOMPDC structures shown in Tables 2 and 3.  All 18 structures form stable dimers. 
The monomers within each dimer are connected by a noncrystallographic two-fold axis 
in all 18 structures.      
 Representative electron density for the Q185A mutant liganded with BMP is 
shown in Figure 16. 
 Final crystallographic refinement statistics for all determined MtOMPDC structures 
are provided in the Tables 2 and 3.  
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Figure 16. Representative electron density map for the active site of the Q185A 
mutant complexed with BMP and contoured at 1.5 Å. The figure was produced with 
PyMOL (41). The details of the interactions between BMP and the active site are 
described in the text.
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RESULTS AND DISCUSSION 
 
Intrinsic Binding Energy (IBE) of the 5’-Phosphate Group.  As described by 
Jencks (23), the IBE of a remote substituent, e.g., the 5’-phosphate group of OMP, is 
used “to pay for substrate destabilization through distortion, electrostatic interactions, 
and desolvation, for bringing about the necessary loss of entropy by freezing the 
substrates in the proper position for reaction, and for binding to the transition state.  
The maximum binding energy is then not realized directly in the binding of the 
substrate, but is more completely realized in the transition state.”  For MtOMPDC, the 
5’-phosphate group of OMP “activates” decarboxylation 2.4 x 108-fold as measured by 
comparing the values of kcat/KM for OMP and EO that lacks the 5’-phosphate group 
[Scheme 2 (19, 26, 32)], 2.9 x 106 M-1 sec-1 and 12.4 x 10-3 M-1 sec-1, respectively 
(Table 4); the IBE calculated from this ratio is 11.4 kcal/mol (Table 4)].   
The challenge has been to provide a structure-based understanding for how the IBE of 
a “remote” group of the substrate is both generated and used to activate the enzyme.  
Given the conformational change induced by ligand binding (Figure 15), a plausible 
explanation is that in MtOMPDC the IBE of the 5’-phosphate group not only increases 
the affinity of the enzyme for the substrate [Ks (and Ks’) in the kinetic model in 
Scheme 2/Figure 17; green arrows in Figure 17] but also increases the fraction of 
the enzyme that exists as Ec•S instead of Eo•S (Kc >> 1 in contrast to Kc’ << 1 for Ec 
and Eo; red and blue arrows, respectively, in Figure 17) by enabling stabilizing 
contacts between the “mobile” and “fixed” domains.  
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Table 4. Kinetic Constants for OMP at pH 7.1 and 25 ˚C. 
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Figure 17. Three-dimensional free energy diagram for the kinetic model depicted in 
Scheme 2.  See the text for a detailed explanation. 
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Model to Explain the Role of the IBE of the 5’-Phosphate Group in the 
Activation of MtOMPDC.  We previously proposed the kinetic model in Scheme 2 to 
understand the relationships among Eo, Ec, S, and the values of KM and kcat (19); the 
three-dimensional energy diagram for the model is shown in Figure 17.  
 In the model, Eo predominates in the absence of substrate (KC’ << 1); Ec 
predominates in its presence (KC >> 1; as Ec•S).  The values of Kc’ and Kc are 
determined by the relative stabilities of Eo and Ec in the absence and presence of 
substrate, respectively.  The dissociation constant for S, [Eo][S]/[Ec•S], is assumed to 
be the value of KM, 1/[Kc•Ks] (= 1/[Kc’•Ks’]).3   
 The value of the IBE for the 5’-phosphate group is obtained from the increase in 
the value of kcat/KM associated with the 5’-phosphate group occupying its binding site in 
Ec (from the ratio of the values for OMP and EO).  Because the carboxylate group of the 
substrate (in either OMP or EO) is distal from the binding site for the 5’-phosphate 
group (Figure 14), the value of kcat (the energy difference between Ec•S and Ec•S‡) 
can be expected to be independent of the absence/presence of the 5’-phosphate group 
in the absence of “long range” interactions with the carboxylate group of the substrate 
and/or the anionic intermediate, i.e., the same value for OMP and EO if it were possible 
to fully populate Ec•S when EO is the substrate.  The model also assumes that 
interaction of the 5’-phosphate group is required to stabilize Ec•S relative to Eo•S (Kc vs. 
Kc’ in the unliganded enzyme), so the value of kcat for EO is determined by the fraction 
of the unliganded enzyme that exists as Ec, i.e., from the value of Kc’.  
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 The energy obtained from the 5’-phosphate group interacting with its binding 
site (available to OMP but not EO) can be used to 1) increase the stabilities of the Eo•S 
and Ec•S complexes relative to Eo + S (green arrows in Figure 17; “gripping” the 
substrate); and 2) increase the stability of Ec•S relative to EoS (red arrows in Figure 
17; stabilizing the active conformation).   Both effects stabilize the Ec•S complex 
relative to Eo + S, thereby decreasing the value of KM and increasing the value of 
kcat/KM. Thus, the activation by the 5’-phosphate group is caused by two independent 
effects that cannot be deconvoluted:  effects on Ks and/or Kc when OMP is the 
substrate.  If the value of kcat is independent of the interactions of the 5’-phosphate 
group with its binding site (evaluated by the loss of individual interactions by 
site-directed mutagenesis; vide infra), the activation by the 5’-phosphate group is the 
result of 1) an increase in the affinity of the enzyme for the OMP substrate (reflected in 
the value of Ks), and 2) an increase in the fraction of the enzyme that exists as Ec (as 
Ec•S, i.e., Kc vs. Kc’).   
 The stability of Ec•S relative to Eo + S (measured by the KM) is also influenced by 
residues “remote” from the binding site for the 5’-phosphate group.  The structures of 
the unliganded and BMP-liganded structures of MtOMPDC allow the proposal that the 
hydrophobic cluster involving Val 182 in the active site loop as well as hydrogen bonds 
involving Thr 159, Arg 160, and Tyr 206 between the “mobile” and “fixed” domains 
observed in Ec but not in Eo contribute to the stability of Ec relative to Eo both in the 
absence and presence of ligand  (Kc’ and Kc, respectively; blue arrows in Figure 17).   
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 In our initial studies of this model, we observed that Ala substitutions for 
residues in the hydrophobic cluster (Val 182, Ile 199, Val 201, and Ile 218) that are 
“remote” from the 5’-phosphate group and its binding site increase the value of KM but 
do not influence the value of kcat (19).  We determined the structures of the mutants in 
the presence of BMP and observed that they are superimposable on that of wild type 
with the exception of the side chains of the substituted residues.  Thus, the changes in 
the values of KM could be associated with an incomplete “remote” hydrophobic cluster 
that reduces the values of both Kc’ and Kc (blue arrows in Figure 17);  the unchanged 
values for kcat were explained by the unperturbed interactions of the active site with the 
OMP substrate and transition state in the Ec•S and Ec•S‡ complexes (Figure 14), so the 
energy difference between Ec•S and Ec•S‡ is unchanged.   
  The Ala substitutions in the hydrophobic core do not alter the values of the 
IBEs, i.e., the values of kcat/KM for OMP and EO are equivalently reduced by the 
substitutions (19).  Because the values for EO measure the fraction of the unliganded 
enzyme present as Ec (the value of Kc’), the equivalent reductions demonstrate that the 
interaction of the 5’-phosphate group with its binding site is not the sole determinant of 
the stability of the Eo•S complex relative to Eo + S (KM = 1/[Kc•Ks]) and of Ec relative to 
Eo in the Ec•S and Eo•S complexes (Kc). 
 In the remainder of this manuscript and in the context of this model, we 
investigate the roles of the hydrogen-bonding interactions involving Thr 159, Arg 160, 
and Tyr 206 between the “mobile” and “fixed” domains observed in Ec but not in Eo as 
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well as Gln 185 and Arg 203 that contribute to the binding site for the 5’-phosphate 
group in the activation by the 5’-phosphate group of OMP.  
Identification of Interactions at the Domain Interface That Stabilize Ec. 
MtOMPDC undergoes a conformational change from Eo in the absence of a ligand to Ec 
in the presence of BMP.  As discussed in the Introduction, this conformational change 
involves closure of the active site loop (Pro 180 to Asp 188; yellow backbone in Figure 
15) as well as the movement of a “mobile” domain (β-strands 6, 7, 8, and 1; red α-
helices and blue β-strands in polypeptide A in Figure 18) toward a “fixed” domain 
(β-strands 2, 3, 4, and 5; magenta α-helices and green β-strands), with the “fixed” 
domains forming the dimer interface.   
When the active site loop becomes ordered in Ec (yellow backbone in Figures 15 and 
16), the hydrophobic cluster involving Val 182 in the active site loop is assembled [Val 
182, Ile 199, Val 201, and Ile 218 (19); cyan residues in Figure 18], and 
hydrogen-bonding contacts also “remote” from the binding site for the 5’-phosphate 
group are established between the “mobile” and “fixed” domains (Tyr 206 with Lys 82 
in the symmetry related polypeptide in the dimer, Thr 159 with the backbone carbonyl 
oxygen of Ser 127, and Arg 160 with the backbone carbonyl oxygens of both Met 126 
and His 128; dark cyan residues in Figure 18).  Enlarged views of these interactions 
are shown in Figure 19 (Gln 185 and Arg 203 that interact directly with the 
5’-phosphate group are colored brown).  Our hypothesis is that these “remote” 
interactions at the domain interface also contribute to the stability of Ec relative to Eo as 
we previously concluded for the hydrophobic cluster (19).   
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Thr 159, Arg 160, and Tyr 206 in the “mobile” domain were targeted, with the 
expectation that substitutions of these with Ala (Thr 159 and Arg 160) or Phe (Tyr 206) 
would destabilize Ec (as determined by the values of kcat/KM for EO).  The substitutions 
were not expected to alter the IBE, as previously observed for the residues that 
participate in the hydrophobic cluster at the base of the active site loop (19), because 
they are “remote” from the binding site for the 5’-phosphate group.  
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Figure 18. The structure of the dimer of MtOMPDC liganded with BMP, with the 
residues studied in this manuscript labeled. Ile 199, Val 201, and Ile 218 that 
participate in the hydrophobic cluster near the N-terminus of the active site loop (with 
Val 182) are also labeled (19).  
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Figure 19. Interactions formed by closure of the “mobile” and “fixed” domains.  Panel 
A, the hydrophobic cluster involving Val 182 at the N-terminus of the active site loop.  
Panel B, the hydrogen bond between Tyr 206 and Lys 82* in the symmetry-related 
polypeptide in the dimer.  Panel C, the hydrogen bonds involving 1) the OH group of 
Thr 159 and the backbone carbonyl oxygen of Ser 127 and 2) the guanidinium group of 
Arg 160 and the backbone carbonyl oxygens of Met 126 and His 128. 
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Identification of Interactions That Generate the IBE of the 5’-Phosphate 
Group.  Each of the nonesterified oxygens of the 5’-phosphate group participates in 
three hydrogen-bonds (a total of nine).  As shown in Figure 20, panel A, the 
5’-phosphate group of BMP directly contacts the carboxamide nitrogen of the side chain 
of Gln 185 in the active site loop (via a single hydrogen bond) and the guanidinium 
group of Arg 203 at the end of the eighth b-strand in the “mobile” domain (via two 
hydrogen bonds); it also contacts the backbone amide groups of Gly 202 and Arg 203 
(via a single hydrogen bond to each).  The importance of the interactions with the side 
chains of Gln 185 and Arg 203 in determining the activation by the 5’-phosphate group 
can be quantitated by characterization of mutants in which the side chains are 
“removed”, e.g., the Q185A and R203A substitutions.  However, the importance of the 
interactions with the backbone amide groups cannot be investigated by site-directed 
mutagenesis-based approaches. 
 In addition, the 5’-phosphate group is hydrogen-bonded to four water molecules, 
with three participating in hydrogen bonds to the backbone amide groups of Gly 181, 
Val 182, and Gln 185 in the active site loop; the fourth water molecule is 
hydrogen-bonded to both Tyr 206 in the “mobile” domain and Asp 20 in the “fixed” 
domain.  The importance of these “indirect” contacts of the 5’-phosphate group with 
the protein also is difficult to investigate using site-directed mutagenesis-based 
approaches. 
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Figure 20. Hydrogen-bonding interactions of the nonesterified oxygens of the 
5’-phosphate group of BMP.  Panel A, the active site of MtOMPDC (details are provided 
in the text).  Panel B, the active site of ScOMPDC (details are provided in the text).  The 
water molecules that are involved in hydrogen bonds to the 5’-phosphate groups are 
colored green. 
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Our hypothesis is that all of the contacts made by the 5’-phosphate group are used to 
generate the total interaction energy that is partitioned between 1) “gripping” the 
substrate (Ks in Scheme 2/Figure 17; green arrows); and 2) stabilizing both Ec•S and 
Ec•S‡ (vide infra) relative to Eo•S (Kc in Scheme 2/Figure 17; red arrows). When the 
active site loop assumes its closed conformation when Gln 185 interacts with the 
5’-phosphate group and the hydrophobic cluster involving Val 182 is formed, 
hydrogen-bonding contacts involving the loop’s backbone, including the carbonyl 
oxygen of Pro 180, reposition the spatially proximal Thr 159 and Arg 160 in the 
“mobile” domain so that their side chains can form hydrogen bonds across the domain 
interface to the backbone carbonyl oxygens of Ser 127 as well as those of Met 126 and 
His 128 that flank Ser 127 in the “fixed” domain.   The carboxamide oxygen of Gln 185 
also forms a hydrogen bond with the OH group of Ser 127 in the “fixed” domain.  Thus, 
we propose that IBE generated by the 5’-phosphate group is used, in part, to enable 
assembly of the hydrophobic cluster at the base of the active site loop as well as the 
interactions across the domain interface, with these providing independent 
contributions to the stabilization of Ec•S and Ec•S‡ relative to Eo•S (Figures 18 and 
19). 
 Gln 185 and Arg 203 were targeted for site-directed mutagenesis, with the 
expectation that Ala substitutions would destabilize Ec•S and Ec•S‡ relative to Eo + S as 
judged by a decrease in the IBE as the result of a reduction in the value of kcat/KM for 
OMP but not for EO.  Although the Q185A could be expected to decrease the value of 
Kc because of the interaction of the carboxamide group with Ser 127 in the “mobile” 
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domain (Figure 14; as measured by the value of kcat/KM for EO), R203A is not 
expected to alter the value of Kc because it is “remote” from the domain interface. 
 Structures of Mutants of Residues that Stabilize Ec.  Five single mutants of 
residues that stabilize Ec [T159A, T159S, T159V, R160A, and Y206F; V182A was 
previously described and structurally characterized (19)] as well as six double/triple 
mutants that combine four of these (T159V/V182A, T159V/Y206F, R160A/V182A, 
R160A/Y206F, V182A/Y206F, and T159V/V182A/Y206F) were constructed and 
subjected to structural characterization in the presence of BMP.  In these structures, the 
catalytic triads, Asp 70, Lys 72, and Asp 75* (from the symmetry related polypeptide in 
the dimer) as well as Ser 127 that hydrogen-bonds to the pyrimidine ring, superimpose 
well on the wild type enzyme (Figure 21).  With the exception of the T159A 
substitution, the only structural changes are those associated with the side chain of the 
substituted residue; in the case of T159A, the conformation of the loop flanking the 
substitution (Pro 157 – Arg 163) is altered.  Not surprisingly, the T159A mutant 
displayed significantly compromised kinetic constants (the value of kcat/KM is reduced 
104-fold from that measured for wild type; data not shown) compared to all of the other 
mutants of residues that stabilize Ec.  Our observation that the values of kcat measured 
for the remaining mutants are “unchanged” relative to that measured for the wild type 
enzyme is consistent with the observation that the structures of the active sites are not 
perturbed by the substitutions. 
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Figure 21. Superposition of the BMP-liganded structures of wild type MtOMPDC and 
the K82A, T159V, R160A, Y206F, T159V/V182A, T159V/Y206F, V182A/Y206F, and 
T159V/V182A/Y206F mutants of residues that stabilize Ec.  Panel A, the polypeptide 
dimers.  Panel B, structures of the active sites. 
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 Structures of Mutants of Residues that Generate the IBE of the 
5’-Phosphate Group.  We constructed the Q185A and R203 single substitutions as 
well as the Q185A/R203A double substitution to remove the direct contacts between 
the 5’-phosphate group and the side chains of the protein.  In the structure of the 
Q185A/R203A double mutant, the active site loop (Pro 180 to Asp 188) is partially 
disordered in the A polypeptide (Ala 184 and Ala 185; with increased B-values for the 
remaining “visible” loop residues) and assumes an altered conformation (also with 
increased B-values) in the B polypeptide (Figure 22). 
 In the mutant proteins, the structures of the active sites are not affected by the 
substitution(s); this is consistent with our observation that the values of kcat for the 
Q185A and R203A single mutants are “unchanged” from that measured for wild type 
enzyme (vide infra); the value of kcat could not be measured for the Q185A/R203A 
double mutant because the value of KM is significantly elevated (Ks is significant 
decreased) by the loss of these contacts with the 5’-phosphate group.  In the Q185A 
and Q185A/R203A mutants, two “new” water molecules occupy the position of the 
carboxamide group of Gln 185 in the wild type enzyme:  one is located in the same 
position as the carboxamide amino group and is hydrogen-bonded to one of the 
nonesterified phosphoryl oxygens; the second is located in the same position as the 
carboxamide carbonyl oxygen and is hydrogen-bonded to both the first water molecule 
and the OH group of Ser 127.  This hydrogen-bonded “chain” maintains an indirect 
interaction of the 5’-phosphate group with the “fixed” domain and, therefore, is 
expected to contribute the stability of the domain interface although the carboxamide 
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group is “missing”.  Finally, in the R203A and Q185A/R203A mutants, a “new” water 
molecule located in the same position as the e-nitrogen of the guanidinium group in the 
wild type protein is hydrogen-bonded to a second nonesterified oxygen.  
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Figure 22. Superposition of the BMP-liganded structures of wild type MtOMPDC and 
the Q185A, R203A, and Q185A/R203A mutants of residues that generate the IBE of the 
5’-phosphate group.  Panel A, the polypeptide dimers.  Panel B, active site of wild type.   
Panel C, active site of the Q185A mutant.   Panel D, Active site of the R203A mutant.  
Panel E, active site of the Q185A/R203A mutant. The red spheres represent water 
molecules. 
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 Structures of Double Mutants of Residues that Stabilize Ec and 
Generate the IBE of the 5’-Phosphate Group.  The R203A substitution was 
combined separately with the spatially remote T159V, R160A, and V182A substitutions.   
As expected based on the structures of the single substitutions and the unchanged 
values for kcat (vide infra), the structures of the active sites were unchanged in the 
mutants (Figure 23).  Also, as in the structure of R203A, in each structure a “new” 
water molecule is located in the same position as the e-nitrogen of the guanidinium 
group in the wild type protein. 
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Figure 23. Superposition of the BMP-liganded structures of wild type MtOMPDC and 
the T159V/R203A, R160A/R203A, and V182A/R203A double mutants of residues that 
stabilize Ec and generate the IBE of the 5’-phosphate group.   Panel A, the polypeptide 
dimers.  Panel B, structures of the active sites. 
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 Kinetic Constants for Mutants of Residues that Stabilize Ec.  The values 
of kcat, KM, and kcat/KM using OMP as substrate were determined for the wild type and 
mutants that contain “remote” substitutions for residues hypothesized to stabilize Ec 
relative to Eo (Table 4).   The values of kcat/KM for EO and/or FEO, (kcat/KM)/KD for 
activation of decarboxylation of EO by phosphite (the ability of phosphite to mimic the 
5’-phosphate group), and the IBEs for the 5’-phosphate group also were determined 
(Table 5). 
For the double/triple mutants, the more reactive FEO was used to estimate the values 
of kcat/KM for EO (25, 33, 34).  For these mutants, the values of KM for OMP and, 
therefore, both EO and FEO are significantly elevated because the fraction of the 
enzyme that exists as Ec is reduced (Kc’ is reduced; blue arrows in Figure 17) because 
interactions that stabilize Ec are absent.  Because of the increased reactivity of FEO, 
lower concentrations of enzyme (and/or shorter reaction times) can be used to measure 
the values of kcat/KM, thereby making these measurements possible.  The correction 
factor for the double/triple mutants, 550, was obtained by averaging the values of the 
ratios of kcat/KM for EO and FEO for wild type MtOMPDC and the single mutants (Table 
5). 
 For the single and most of the double mutants using OMP as substrate, the 
values of kcat are “unchanged” relative to that measured for wild type enzyme; in 
contrast, the values of KM are significantly increased.  [The values for kcat for OMP are 
(modestly) decreased for the T159V/V182A and 
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Table 5.  Kinetic Constants for EO and FEO and IBEs of the 5'-Phosphate Group of 
OMP at pH 7.1 and 25 ˚C. 
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 T159V/V182A/Y206F mutants, suggesting small changes in structure and/or dynamics.]  
These observations are similar to those we reported for Ala substitutions for the 
residues in the hydrophobic cluster at the base of the active site loop that includes Val 
182 (19).  The increases in the values of KM for the double/triple mutants are 
approximately multiplicative relative to the single mutants (additive in free energy), 
providing support that these “remote” residues provide “independent” contributions that 
stabilize Ec•S relative to Eo + S. 
 The values of kcat/KM for EO for the single mutants are decreased from that 
measured for wild type; the calculated values for the double/triple mutants are more 
significantly reduced, with the changes again approximately multiplicative relative to the 
single mutants.  That the fold-decreases in the values of kcat/KM for OMP and EO are 
equivalent reinforces the interpretation that the targeted residues are important in 
determining the stability of Ec, i.e., the substitutions give decreased values for Kc and 
Kc’ (blue arrows in Figure 17). 
 The values of (kcat/KM)/KD for activation of the decarboxylation of EO by 
phosphite were determined for the single mutants; these demonstrate that phosphite 
retains the ability to activate the mutants.  That the values of kcat/KM for OMP, kcat/KM 
for EO, and (kcat/KM)/KD for phosphite are equivalently decreased is consistent with the 
interpretation that the changes are determined by the values of Kc, i.e., the 
5’-phosphate group of OMP and phosphite both retain the ability to increase the 
stability of Ec•S (and E•S‡) relative to EoS (red arrows in Figure 17) 
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 As a result of the equivalent effects of the substitutions on the values of the 
values of kcat/KM for OMP and EO, the IBEs for the 5’-phosphate group for the single 
and most of the double mutants are unchanged from that measured for the wild type 
enzyme; the same observation was made for Ala substitutions for the residues in the 
hydrophobic cluster (19).  [For the T159V/V182A and T159V/V182A/Y206F mutants, the 
values of the IBEs are modestly decreased, likely the result of the same small structural 
changes that may affect the values of kcat.]  We conclude that although the 
5’-phosphate group provides the same IBE, Ec•S and E•S‡ are less stabilized for the 
mutants than the wild type enzyme because the interactions that stabilize the closed 
conformation of the active site loop (Val 182) and stabilize the domain interface (Thr 
159, Arg 160, and Tyr 206) have been disrupted.   
 Kinetic Constants for Mutants of Residues that Generate the IBE of the 
5’-Phosphate Group.  Using both OMP and EO, we measured the values of kinetic 
constants for Q185A, R203A, and Q185A/R203A, the two single mutants and one 
double mutant with substitutions for the two residues with side chains that directly 
contact the 5’-phosphate group of the substrate (Tables 4 and 5).  With OMP, the 
values of kcat and KM and, therefore, kcat/KM could be measured for Q185A and R203A; 
however, only the value kcat/KM could be measured for Q185A/R203A.   
 The values of kcat for the Q185A and R203A mutants are “unchanged” from that 
measured for wild type enzyme (Table 4), so the energy difference between the Ec•S 
and Ec•S‡ complexes is not affected by the decreased ability of the “remote” 
5’-phosphate group to activate the enzyme.  Therefore, these substitutions alter the 
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energies of both Ec•S and Ec•S‡ relative to Eo + S, i.e., the 5’-phosphate group does not 
preferentially stabilize the transition state complex, Ec•S‡, but also stabilizes the 
Michaelis complex, Ec•S, because both share the Ec conformation.   
 The values of kcat/KM for OMP are decreased but the values for EO are 
“unchanged” from that measured for wild type.  The decreased value for OMP is 
explained by the weaker affinity of enzyme for the 5’-phosphate group, i.e., a decrease 
in the value of Ks (green arrow in Figure 17).   That the values for EO are unchanged 
provides evidence that Gln 185 and Arg 203 are not involved in determining the relative 
energies of Eo and Ec.4 Thus, we hypothesize that the IBE enables the conformational 
reorganization of the active site loop that allows formation of the interdomain contacts 
involving Thr 159, Arg 160, and Tyr 206 as well as assembly of the hydrophobic cluster 
involving Val 182 in the active site loop, with these determining the stability of Ec 
relative to Eo. 
 The value of the IBE for the wild type enzyme is 11.4 kcal/mol (Table 5).  For 
the Q185A and R203A mutants, the values are decreased by 2.1 and 4.0 kcal/mol, 
respectively; for Q185A/R203A, the value is decreased by 6.7 kcal/mol (approximately 
the sum of the those for the single mutants).  But, despite the complete absence of the 
direct contacts of the 5’-phosphate group with side chains, the Q185A/R203A mutant is 
activated 2,900-fold by the 5’-phosphate group (the IBE is 4.7 kcal/mol).  The 
5’-phosphate group retains its interactions with the backbone amide groups of Gly 202 
and Arg 203 as well as several ordered water molecules, including one that also 
hydrogen-bonds with Asp 20 in the “fixed” domain (Figure 20A).   
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 The values of (kcat/KM)/KD for activation of the decarboxylation of EO by 
phosphite were also determined for the single mutants.  The values are decreased 
significantly, as expected because the values of Ks for phosphite binding should be 
decreased by the absence of these direct interactions.  
That the side chain contacts with the 5’-phosphate group are not entirely responsible 
for generating the IBE of the 5’-phosphate group contrasts with results we reported for 
similar mutagenesis-based experiments with the OMPDC from Saccharomyces cerevisiae 
(ScOMPDC)  (35).  In ScOMPDC, the 5’-phosphate group interacts with the side chains 
of three residues, Gln 215 and Arg 235, structural homologues of Gln 185 and Arg 203 
in MtOMPDC, as well as Tyr 217 in the longer (19-residue) active site loop (Figure 
20B).  In ScOMPDC, the 5’-phosphate group is hydrogen-bonded to the backbone 
amide groups of Gly 234 and Arg 235, structural homologues of Gly 202 and Arg 203 in 
MtOMPDC.  Also, in ScOMPDC, the 5’-phosphate group is hydrogen-bonded to three 
(not four) water molecules, two hydrogen-bonded to the backbone of the active site 
loop and the third hydrogen-bonded to Asp 37, the structural homologue of Asp 20 in 
MtOMPDC.   
Kinetic analyses for single and multiple substitutions for the residues that contact the 
5’-phosphate group (Q215A, Y217F, and R203A) revealed progressive decreases in the 
values of the IBE, with the values of kcat/KM for OMP only 12-fold greater than that for 
EO for the Q215A/Y217F/R235A triple mutant.  An explanation for why the direct 
contacts with the side chains apparently are “fully” responsible for generating the IBE in 
ScOMPDC but not in MtOMPDC is not obvious.  However, the active site loops differ in 
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both length and conformation; also, structures are not available for the mutants of 
ScOMPDC, so unlike MtOMPDC, the effects of the substitutions on the structure of the 
protein and active site cannot be assessed.   
 Kinetic Constants for Double Mutants of Residues that Stabilize Ec and 
Generate the IBE of the 5’-Phosphate Group.  To obtain evidence that the 
“remote” interactions that stabilize Ec•S and Ec•S‡ relative to Eo•S and those that 
generate the IBE of the 5’-phosphate group by direct contacts are independent, we 
constructed and characterized the R203A/T159V, R203A/R160A, and R203A/V182A 
double mutants.  We chose the R203A instead of the Q185A substitution because Gln 
185 is hydrogen-bonded not only to the 5’-phosphate group but also to the OH group of 
Ser 127 in the “mobile” domain, i.e., Gln 185 could contribute to both stabilization of Ec 
(and, therefore, the value of Kc’) as well as generation of the IBE; in fact, the Q185A 
substitution does cause a six-fold decrease in the value of kcat/KM for EO.4  The kinetic 
constants for these mutants also are included in Tables 4 and 5. 
 The values of kcat and KM for OMP could not be measured for these mutants:  
because all of the single mutants effect the stabilities of Ec•S relative to Eo + S, the 
values of the KM were expected to be and are, in fact, too large to be measured (Table 
4).  The values of kcat/KM for EO for the double mutants are essentially identical to 
those measured for the T159V, R160A, and V182A single mutants that alter the stability 
of Ec •S relative to Eo, i.e., the value of kcat/KM for EO for the R203A mutant is 
“unchanged” (only two-fold decreased) from that measured for the wild type enzyme 
(Table 5).  Thus, the effects of the substitutions are additive with respect to 
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stabilization of Ec in both Ec•S and Ec•S‡.  Also, the values for the IBE for the 
5’-phosphate group are essentially the same as that measured for the R203A mutant, 
i.e., the effects of the substitutions on the IBE also are additive (Table 5).   
Independent Structural Strategies to Enable and Accomplish the Stabilization 
of Ec. Taken together, our structural and kinetic observations provide persuasive 
evidence that the model presented in Scheme 2/Figure 17 provides a structure-based 
understanding of how the IBE of the 5’-phosphate group is both generated and used to 
activate the enzyme.  The direct interactions of the 5’-phosphate group with the side 
chains of Gln 185 in the active site loop and Arg 203 (as well as the backbone amide 
groups of Gly 202 and Arg 203 and water molecules that interact with the active site 
loop; green arrows in Figure 17) organize the active site loop (red arrows) so that the 
hydrophobic cluster at the base of the active site loop and the “remote” interdomain 
interactions can be formed to stabilize Ec•S and Ec•S‡ relative to Eo•S (blue arrows). 
This “cascade” of structurally expanding interactions, triggered by the binding of OMP 
to Eo and likely orchestrated by changes in the structure of the active site loop directed 
by the “remote” 5’-phosphate group, results in the remarkable 2.4 x 108-fold rate 
enhancement as the stabilizing/destabilizing interactions are enforced in Ec•S and Ec•S‡.  
Further studies of interactions of the 5’-phosphate group with its binding site, including 
the importance of the water-mediated contacts with the active site loop, are in 
progress. 
Conclusions.  The importance of the IBEs of “remote” substituents in achieving the 
transition state stabilization that are responsible for the impressive rate enhancements 
 
 
92 
of enzyme-catalyzed reactions has long been recognized (23).  However, a unifying 
structure-based description and understanding for how the IBE of remote substituents 
is generated and used to effect transition state stabilization has been elusive.  Like 
triose phosphate isomerase (22), MtOMPDC provides a useful system to explore and 
define how the IBE of the “remote” phosphate group of the substrate is generated and 
used to contribute to its impressive 1017 rate acceleration:  the reaction is unimolecular 
and requires no cofactors, the wild type enzyme and mutants can be structurally 
characterized, a sensitive direct spectrophotometric assay is available, and substrate 
analogs (EO and FEO) can be used to “isolate” the role of the activating 5’-phosphate 
group.  Prior structural characterization established that substrate binding in MtOMPDC 
is accompanied by a conformational change in which a catalytically active, closed 
conformation (Ec) that is unfavorable in the absence of the substrate predominates 
when substrate is bound.  We now have obtained persuasive kinetic and structural 
evidence that the IBE of the 5’-phosphate group provides the energy for a local 
reorganization of the structure of its binding site in the Eo•S complex (in particular, the 
ordering of the active site loop that includes Gln 185) that then enables the formation 
of additional “remote” interactions at the interface between the “mobile” and “fixed” 
domains that provide the energy to stabilize Ec in both the Ec•S and Ec•S‡ complexes.  
We expect that this strategy will be applicable to understanding the structural basis for 
the activation of other enzymes that undergo an essential conformational change from 
an open, inactive conformation (Eo) to a closed, active conformation (Ec) as the result of 
substrate binding.  
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Our studies using both the intact OMP substrate and EO/FEO that lack the 5’-phosphate 
group (19, 25, 26, 32) provide a kinetics/structure-based approach for understanding 
the role of the substrate and the IBE of its pieces in enabling the conformational 
changes that are required for efficient enzymatic catalysis.  The dynamic characteristics 
of conformational changes that accompany catalysis have been studied in other 
enzymes, including adenylate kinase (36, 37) and dihydrofolate reductase (38-40).  The 
principles that emerge from the kinetics-based approaches described in this manuscript 
and previous studies of triose phosphate isomerase (22) as well as dynamics-based 
approaches that employ time-resolved NMR spectroscopy, isotope exchange, and 
simulations together 1) provide both a description and an understanding of Nature’s 
structural strategies for achieving large rate accelerations, and 2) inform the (re)design 
of enzymic catalysts for novel reactions by revealing the requirements for substrate 
binding to Eo, utilization of energy provided by binding interactions with “remote” 
portions of the substrate to, in part, effect a necessary conformational transition from 
Eo•S to Ec•S that allows catalysis via Ec•S‡, and, finally, a favorable conformational 
relaxation to Eo to permit product dissociation. 
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CHAPTER 4: COMPUTATIONAL, STRUCTURAL AND KINETIC EVIDENCE THAT VIBRIO 
VULNIFICUS FRSA IS NOT A COFACTOR-INDEPENDENT PYRUVATE DECARBOXYLASE 
 
ABSTRACT: The fermentation-respiration switch (FrsA) protein in Vibrio vulnificus was 
recently reported to catalyze the cofactor-independent decarboxylation of pyruvate. We 
now report QM/MM calculations that examine the energetics of C-C bond cleavage for a 
pyruvate molecule bound within the putative active site of FrsA. These calculations 
suggest that the barrier to C-C bond cleavage in the bound substrate is 28 kcal/mol, 
which is similar to that estimated for the uncatalyzed decarboxylation of pyruvate in 
water at 25 oC. In agreement with the theoretical predictions, no pyruvate 
decarboxylase activity was detected for recombinant FrsA protein that could be 
crystallized and structurally characterized. These results suggest that the functional 
annotation of FrsA as a cofactor-independent pyruvate decarboxylase is incorrect. 
 
     A recent report identified the fermentation-respiration switch (FrsA) protein in Vibrio 
vulnificus to be a cofactor-independent pyruvate decarboxylase (Scheme 4) (1). 
Indeed, FrsA was reported to exhibit a kcat of approximately 1400 s-1 at 37 oC, which is 
considerably greater than the value observed for the turnover number of the thiamin-
dependent pyruvate decarboxylase from Saccharomyces cerevisiae (2) 
 
Reprinted (adapted) with permission of Kellett, W. F.; Brunk, E.; Desai, B. J.; Fedorov, A. A.; Almo, S. C.; Gerlt, J. A.; 
Rothlisberger, U.; Richards, N. G. Biochemistry 2013, 52, 1842-1844. DOI: 10.1021/bi400093y. Copyright 2013 
American Chemical Society. 
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This remarkable finding, if correct, would imply a significant shift from the current 
paradigm that Nature evolved the thiamin co-factor to generate resonance-stabilized 
acyl carbanion equivalents in all kingdoms of life when catalyzing the oxidative and non-
oxidative decarboxylation of α-ketoacids. 
 
 
Scheme 4. Cofactor-independent decarboxylation of pyruvate showing the putative 
acyl anion intermediate. 
 
 
     The X-ray crystal structure of unliganded FrsA,1 which revealed a putative active site 
containing similar residues to those present in orotidine 5’-monophosphate 
decarboxylase (OMPDC), (3-5) provided a chemical rationale for the unexpected 
functional assignment of FrsA. Thus, it was argued that the catalytic power of the 
enzyme derived from electrostatic repulsion between pyruvate and the negatively 
charged side chain of Asp-203 in FrsA (1). We were intrigued by these conclusions for 
two reasons. First, the three-dimensional fold of FrsA places it within the α,β-hydrolase 
superfamily of enzymes, (6) which are known to catalyze a diverse array of reactions 
(7) including the decarboxylation of β-ketoacids to yield methylketones (8). OMPDC has 
a different fold, however, and this lack of structural similarity precludes any direct 
evolutionary relationship between the two enzymes (5). Second, considerable evidence 
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exists to suggest that stabilization of the carbanion intermediate formed in the OMPDC-
catalyzed reaction is enabled by binding energy obtained from the extensive set of 
interactions of the protein and the sugar-phosphate moiety of the OMP substrate 
(9,10). On the other hand, the energy released by the interaction of the methyl 
substituent with FrsA and the small number of hydrogen bonds to the carbonyl group 
seems insufficient for stabilization of any acyl anion intermediate formed during FrsA-
catalyzed decarboxylation. We therefore used advanced computational methods to 
evaluate the energetics of the proposed mechanism for FrsA-catalyzed conversion of 
pyruvate to acetaldehyde, and also prepared and assayed recombinant Vibrio vulnificus 
FrsA to determine whether the reported activity could be reproduced. 
 
     The model of the FrsA/pyruvate complex used in our computational studies was 
based upon the “open” monomer in the crystal structure of the free enzyme (3MVE). 
After adding hydrogen atoms, the protein was placed in a box of TIP3P water molecules 
(11) containing two chloride ions to yield a neutral system. The resulting structure was 
energy minimized and equilibrated by molecular dynamics (MD) simulation. Parameters 
for pyruvate were obtained from the generalized AMBER force field (12-14) and the 
substrate was docked into the putative enzyme active site using GLIDE (15). Energy 
minimization and MD equilibration of several model complexes with pyruvate in 
different orientations within the putative active site all gave the same final position for 
the substrate (Figure 24).  
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Figure 24. Equilibrated model of pyruvate (orange) docked into the putative active site 
of FrsA. Pyruvate is hydrogen bonding to the backbone NH of Leu-202 and the side 
chains of Tyr-316 and Arg -272. Color scheme: C – cyan; H – white; N – blue; O – red. 
Active site water oxygen atoms are rendered as red spheres. 
 
 
     The final equilibrated structure of the pyruvate/FrsA complex resembled the one 
proposed previously (1), with pyruvate forming hydrogen bonds to the side chains of 
the backbone NH of Leu-202, and the side chains of Arg-272 and Tyr-316. In addition, 
three active site water molecules associated strongly with bound pyruvate throughout 
these MD simulations. This solvated model of the pyruvate/FrsA complex proved to be 
stable in an unconstrained NPT MD simulation over a period of 20 ns, and so was used 
in a series of QM/MM simulations of the C-C bond cleavage reaction employing an 
extension of the Car-Parinello MD (CPMD) methodology (16). The QM region consisted 
of pyruvate, the Tyr-316 side chain up to the Cβ atom, and three active site waters. 
These atoms were described by the BLYP functional (17,18) and norm-conserving 
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Martins-Trouiller pseudopotentials (19) with dispersion-corrected atom-centered 
dispersion potentials (20-22). The remaining atoms, comprising the rest of the protein 
and explicit water molecules, were described by the classical AMBER99 force field 
(13,14). The side chains of the hypothetical “catalytic residues, Asp-203 and Arg-272, 
were not included in the QM region because their putative electrostatic contributions to 
catalysis could be adequately represented using an MM description. In the CPMD 
calculations, the C1-C2 bond distance in pyruvate was chosen as the reaction 
coordinate; hence, constraints were employed at distances spanning 1.55 to 4.24 Å (in 
increments of 25 pm). The QM/MM system was equilibrated for 2 ps at constant 
pressure and temperature before performing constrained MD simulations for 
thermodynamic integration (23,24) in the NPT ensemble. Each system was sampled for 
1 ps and the free energy profile was computed by integrating the constraint forces over 
the respective distances (Figure 25). These simulations gave an estimated free energy 
barrier of 28.1 ± 0.2 kcal/mol for the conversion of FrsA-bound pyruvate into 
acetaldehyde and CO2, corresponding to a first-order rate constant of 1.1 x 10-9 s-1 at 
25 oC, assuming transition state theory and the absence of re-crossing (25). This value 
is very similar to the experimental estimate of the first order rate constant for the 
uncatalyzed decarboxylation of pyruvate, which has an upper limit of approximately 10-9 
s-1 at this temperature and pH 7 (26). The calculated value should be considered as a 
lower bound given that BLYP is known to underestimate activation barriers, especially 
those for proton transfer steps (29). For example, “benchmark” studies give an 
estimate of 23.0 ± 3.1 kcal/mol for the uncatalyzed reaction in water. Certainly both 
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computed barriers are inconsistent with the reported1 turnover number of 1400 s-1 for 
FrsA-catalyzed decarboxylation. 
 
Figure 25. Free energy profile (kcal/mol) for cleavage of the C1-C2 bond in FrsA-
bound pyruvate, as computed by thermodynamic integration. Error bars show the 
statistical sum of errors associated with the calculated free energy. The inset shows the 
active site configuration at the transition state (C-C = 3.3 Å) and the transfer of a 
proton from a hydronium ion to the acyl anion. 
 
 
     Furthermore, the notion that the FrsA protein environment does not catalyze C-C 
bond cleavage is consistent with the fact that the QM/MM simulations suggest that a 
nearby tyrosine residue (Tyr-316) protonates pyruvate during the reaction mechanism 
(Figure 26 and Appendix C). This proton is subsequently transferred to a nearby 
water molecule at the transition state (C-C bond length of 3.1 Å). The resulting 
hydronium ion stabilizes the developing anionic charge on the central carbon atom 
when the C-C bond length in the substrate is elongated to 3.3 Å, and protonates the 
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acyl anion, thereby giving acetaldehyde (Figure 26). Both the initial deprotonation of 
tyrosine by substrate and the subsequent proton transfer to water are counter-intuitive 
on the basis of standard pKa values, and calculations28 do not support any large pKa 
shifts for either Tyr-316 or bound pyruvic acid (Appendix C). These computational 
findings again point to the fact that FrsA is unlikely to be a co-factor independent 
decarboxylase. 
 
     To evaluate the conclusions of the QM/MM and pKa shift calculations, the gene 
encoding Vibrio vulnificus FrsA was expressed in Escherichia coli and purified via two 
different procedures. In agreement with the computational results, neither preparation 
exhibited detectable pyruvate decarboxylase activity (acetaldehyde production or CO2 
evolution) in a coupled-enzyme spectrophotometric assay (alcohol dehydrogenase), by 
1H NMR spectroscopy, or by membrane-inlet mass spectrometry (Appendix C) (29). 
The purified protein was, however, crystallized and its structure determined at 1.95 Å 
resolution; our structure was essentially identical to that reported earlier except an 
unknown ligand, modeled as hexanoate, was located in the putative active site 
(Appendix C, Figure 38). Given that α,β-hydrolase superfamily members are 
functionally diverse, (8) it is difficult to predict in vitro activity solely from sequence 
homology. However, these computational, structural, and experimental results do not 
support the claim that FrsA is a cofactor-independent pyruvate decarboxylase. 
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Figure 26. Molecular events observed during the cleavage of the C1-C2 bond in FrsA-
bound pyruvate. (a) Protonation of the substrate carboxylate by the side chain of Tyr-
316. (b) Deprotonation of the carboxylic acid via a nearby water molecule. (c) 
Formation of a hydronium ion during decarboxylation, which then acts to quench the 
developing anionic charge on C2 thereby yielding acetaldehyde (d). Atoms in the QM 
and MM regions are rendered as “ball-and-stick” and licorice representations, 
respectively. Proton transfers are shown using “dynamic bonds”. Color scheme for the 
QM atoms: C, grey; H, white; O, red. 
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CHAPTER 5: GENERAL CONCLUSIONS  
 
This work has investigated several aspects of OMPDC that are crucial for achieving its 
remarkable catalytic efficiency. Chapter 2 investigates the mode by which the vinyl 
carbanion is stabilized. Our studies shows that interaction with O4 of the substrate is 
not the major means of stabilization of the anion (via the carbene resonance structure). 
Several interactions with the active site, especially interaction with Lys72, play a role in 
transition-state stabilization. Moreover, computational calculations show that the 
negative charge produced in the transition-state is more diffusely distributed over the 
pyrimidine ring, contrary to earlier understanding that the negative charge resides at a 
particular locus, like O4 or C6 of the pyrimidine ring. Therefore multiple interactions 
within the active site are responsible for stabilization of the vinyl carbanion 
intermediate.  Our studies also suggest that transition-state stabilization cannot solely 
account for the 1017 fold rate enhancement, and thus indirectly finding support for 
ground-state destabilization as a means of reducing the activation energy barrier for 
OMP decarboxylation. 
 
     Our studies on residues remote from the active site in Chapter 3 (T159, V182 and 
Y206), show that these residues can stabilize the catalytically competent closed 
conformation of the enzyme (Ec). Mutation of these residues can increase the KM by 
shifting the equilibrium between Eo and Ec towards Eo. This discovery, that KM is a 
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complex that reflects both binding equilibrium and equilibrium between conformational 
states, enriches the current understanding in interpreting kinetic data from enzymes. 
      
     Investigation of phosphate-binding interactions indicates that a majority (~7 kcal 
out of 11.4 kcal), but not all, of the intrinsic phosphate-binding energy is furnished by 
interaction of R203 and Q185 with the 5’-phosphate group. Moreover, our studies 
provide a structural explanation for how intrinsic binding energy can enable a 
conformational change to aid catalysis. Prior to this work, intrinsic phosphate binding 
energy was proposed to provide free energy for catalysis by providing additional 
interactions that manifest only in the transition-state. There was no structural evidence 
for this. Our studies show that intrinsic binding energy is generated by binding 
interactions with residues in the active site of OMPDC in both the ground-state and 
transition-state. These interactions pay for entropic costs of desolvation, enthalpic 
penalty due to GSD and enabling the formation of the catalytically competent Michaelis 
complex or Ec, possibly by changing the conformational landscape of the enzyme. This 
unique role of the remote 5’-phosphate group is important for enforcing strategies 
required for efficient cofactor-less decarboxylation of OMP.  
 
     In Chapter 4, I show that FrsA cannot catalyze cofactor-less decarboxylation of 
pyruvate and therefore is misannotated as a pyruvate decarboxylase. Pyruvate does not 
have a phosphate handle that can provide a large intrinsic binding energy to perform 
the difficult catalytic reaction of pyruvate decarboxylation. Moreover, the active site of 
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FrsA does not provide any stabilization of the carbanion formed after the 
decarboxylation. 
 
     Taken together, this thesis adds a deeper, structure-based understanding of the 
enigmatic efficiency of OMPDC. Principles gained through this work, on strategies for 
stabilization of anionic intermediates and use of remote-substituent binding energy to 
drive catalysis, can be used to guide enzyme engineering/re-engineering efforts.
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Supplemental Methods 
 
All reagents were purchased from Sigma-Aldrich unless stated otherwise.  
[35S]-Methionine was purchased from Perkin-Elmer. All solutions were made in ultra-
pure deionized water. 
 
Plasmids Preparation.  The MtOMPDC gene optimized for Escherichia coli codon 
usage and formation of minimal secondary structure in mRNA transcripts was 
synthesized by Genescript and cloned into the plasmid supplied with NEB PURExpress® 
in vitro translation kit between NdeI and BamHI restriction sites (Table 12). Site-
directed mutagenesis using overlap extension was used to first generate H128N 
mutation by previously established procedures (1-3). The MtOMPDC H128N plasmid 
was used to perform a second round of site-directed mutagenesis to generate gene 
containing MtOMPDC S127Amber/H128N mutation (Table 14). For heterologous 
expression of MtOMPDC H128N from E. coli, the gene was cloned into expression vector 
PET15b between NdeI and BamHI restriction sites. 
 
Purification of MtOMPDC H128N and S127Q from Escherichia coli.  MtOMPDC 
H128N was overexpressed in E. coli BL21 (DE3) and MtOMPDC S127Q was 
overexpressed in E. coli BW25113 OMPDC (pyrF) K/O strain, using previously published 
procedure, with slight modifications (1-3). Overnight starter cultures of the E.coli cells 
transformed with PET15b plasmid containing the MtOMPDC gene were inoculated into 6 
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X 2 L Luria-Bertani (LB) medium containing appropriate antibiotics. The cells were 
incubated for 12-14 hrs with aeration. The cells were harvested by centrifugation at 
4000 g for 10 min. The harvested cells were re-suspended in equilibrating buffer (20 
mM Tris HCl, pH 7.9) and lysed by sonication. The cell lysate was separated by 
centrifugation at 31,000 g. The supernatant lysate was charged onto a pre-equilibrated 
column containing Ni-Sepharose resin (GE Life sciences). The column was washed with 
wash buffer (20 mM Tris, pH 7.9, 500 mM NaCl, 50 mM imidazole) and the bound His-
tagged protein was eluted using elution buffer (20 mM Tris, pH 7.9;,500 mM NaCl, 1 M 
imidazole) by gradient elution. The fractions containing OMPDC (determined by 
SDS-PAGE) were pooled and dialyzed against 1 X PBS. The His-tag was cleaved using 
thrombin (GE Life sciences) at 25° C for 12 hrs. The completion of the cleavage 
reaction was confirmed using SDS-PAGE. The cleaved protein was separated using FPLC 
on a column containing phenyl Sepharose resin (GE Life sciences) pre-equilibrated with 
20 mM Tris  pH 7.9, 1 M (NH4)2SO4. Ammonium sulfate (4M) was added to the protein 
solution to give a final concentration of 1 M. This solution was charged onto the phenyl 
Sepharose column. The protein was eluted by gradient elution using 20 mM, Tris pH 
7.9, as the elution buffer. The fractions containing the cleaved MtOMPDC protein were 
pooled and dialyzed against storage buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 3 mM 
DTT). The dialyzed protein was concentrated to ~17 mg/mL using Millipore Ultracell 
concentrators. The concentrated protein was aliquoted and flash frozen and stored at -
80°C for future use. 
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OMP Decarboxylation Assay of Purified MtOMPDC Wt and H128N. OMP 
decarboxylation assays were carried out using previously published procedure (1-3), at 
25°C in 10 mM MOPS pH 7.5 containing 100 mM NaCl by following the decay in 
absorbance at 279 nm due to formation of UMP (Δε279= 2400 M-1cm-1). OMP stock 
concentration was determined spectrophotometrically at 25°C in 0.1 N HCl, using molar 
extinction coefficient (ε267= 9430 M-1cm-1). Enzyme stock concentration was determined 
at 25°C in 10 mM MOPS pH 7.5 containing 100 mM NaCl using the molar extinction 
coefficient (ε280= 5960 M-1cm-1). A final enzyme concentration of 80 nM was used in the 
assays. kcat was determined by measuring initial velocity (Vo) using saturating 
concentrations of OMP (where Vo is independent of [OMP]). KM was determined by 
following the first order decay at low OMP concentrations (linear dependence of Vo on 
[OMP]). This curve was fit to a first order decay function and the first order constant 
was determined using non-linear regression. This constant represents Vmax/KM. The KM 
was calculated from Vmax/KM using the enzyme concentration and kcat that had been 
previously determined. The kinetic constants for MtOMPDC Wt and H128N are given in 
Table 6. 
 
Preparation of reagents used for in vitro tRNA acylation using Flexizyme  
Preparation of Flexizyme: Flexizyme dFx was prepared using in vitro run-off 
transcription of template DNA encoding dFx using previously published procedures (4, 
5).  The sequence of dFx is given in Table 15. 
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Preparation of amber suppressor tRNA:  Orthogonal suppressor tRNA containing 
an amber anti-codon was prepared using in vitro run-off transcription of DNA template 
encoding the tRNA using previously published procedure (4). The tRNA sequence is 
given below  in Table 15. 
Preparation of activated Ser and HOSer: Ser-DBE was synthesized with the same 
procedure as previously described (6). HOSer-DBE was synthesized using the following 
procedure: L-Glyceric acid hemicalcium salt (180 mg, 1.25 mmol) was dissolved in 1 mL 
of 1 M HCl aq. saturated with NaCl and extracted with 4 mL of THF (5 times). The 
combined organic phase was dried over MgSO4 and evaporated. The residue (L-glyceric 
acid, 122 mg, 1.15 mmol) was mixed with 3,5-dinitrobenzyl chloride (224 mg, 1.03 
mmol) and triethylamine (153 µL, 1.09 mmol) in 0.3 mL of DMF, and the reaction 
mixture was stirred at room temperature for 16 h. After the reaction, Et2O (9 mL) was 
added and the solution was washed with 1 M HCl (3 mL x 3), sat. NaHCO3 (3 mL x 3) 
and brine (5 mL x 1), and the organic layer was dried over MgSO4 and concentrated 
under reduced pressure. The crude residue was purified by silica gel column 
chromatography to give HOS-DBE (197 mg, 55%): 1H NMR (CDCl3, 300 MHz) δ 9.03 (t, J 
= 2.1 Hz, 1H), 8.59 (d, J = 2.1 Hz, 2H), 5.47 (m, 2H), 4.42 (br, 1H), 3.99 (br, 2H), 3.17 
(br, 1H), 2.29 (br, 1H). 
 
Acylation of amber suppressor tRNA using Flexizyme.  Acylation of amber 
suppressor tRNA was achieved by incubation of 25 µM tRNA, 25 µM flexizyme and 5 mM 
activated L-serine (S) or L-glycerate (HOS) at 0 °C in 50 mM HEPES-KOH, pH 7.5, 
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containing 600 mM MgCl2. Before starting the reaction, the components were mixed at 
room temperature, except MgCl2 and S-DBE or HOS-DBE. The mixture was heated at 95 
°C for 3 min in order to denature the flexizyme and tRNA. The mixture was cooled to 
room temperature before adding MgCl2 and activated S-DBE or HOS-DBE.  The reactions 
were incubated at 0 °C for 12 hours.  
      After incubation, the acylated tRNA was precipitated by adding 11 volumes of a 
3:8 mixture of 0.3 M sodium acetate pH 5.2, and 70% ethanol. The precipitated tRNA 
was washed twice using 5 volumes of 70% ethanol containing 0.1 M sodium acetate, 
pH 5.2, and once using 1 volume of 70% ethanol. The resulting pellet was dried at 
room temperature for 5 min and resuspended in RNase free deionized water 
immediately before use. 
 
Quantification of in vitro-Synthesized Proteins.  Wild type (H128N) protein 
synthesized by in vitro translation was quantified by measuring the initial rates of OMP 
decarboxylation at saturating substrate concentrations (Vmax). These rates were 
interpolated on a standard curve of Vmax vs. enzyme concentration generated by known 
quantities of H128N protein expressed in and purified form Escherichia coli. The 
amounts of S127HOS, the H128N positive control (suppression with L-Ser), and negative 
control (S127Q) were quantified using autoradiography by comparing the intensities of 
the full-length, [35S]-methionine labeled proteins with that of the wild type (H128N) 
protein (Figure 34).   
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Autoradiography of in vitro-Synthesized Proteins.  An aliquot (2.5 µL) of the in 
vitro reaction performed in presence of [35S]-methionine was mixed with equal volume 
of SDS loading buffer.  4.5 µL of the resulting mixture was loaded on a 4-20% 
polyacrylamide gradient gel (Biorad). The gel was placed in an electrophoretic cell 
(Biorad) containing SDS PAGE Tris-glycine running buffer and allowed to separate at 
constant voltage of 200 V for 30-35 min. The gel was dried using a vacuum drier 
(Biorad) and used to expose storage phosphorimager cassettes over-night in the dark. 
The cassettes were imaged using Molecular Dynamics Storm phosphorimager. The 
image was analyzed using ImageQuant software and the relative intensity of each 
protein band was determined taking wild type (H128N) as 100% (Figure 34).  The 
concentration of in vitro synthesized wild type (H128N) determined as described 
previously and the relative intensities of the synthesized proteins were used to calculate 
the concentrations of S127HOS and H128N positive control. 
Alkali hydrolysis treatment of in vitro reaction (Chapter 2, Figure 11B) was 
performed by adding 1 µl of 1 M NaHCO3/Na2CO3 buffer, pH 10, to 2.5 µl of each 
reaction and heating at 70°C for 1 hr in a PCR thermocycler, before performing SDS-
PAGE experiments. 
 
Crystallization and Data Collection of MtOMPDC H128N. The crystals of 
MtOMPDC.H128N•BMP (Table 16) were grown by the sitting drop method at room 
temperature. The protein solution contained the MtOMPDC mutant (17 mg/mL) in 20 
mM HEPES, pH 7.5, 150 mM NaCl, 3 mM DTT, and 40 mM 6-hydroxyuridine-5’-
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phosphate (BMP); the precipitant contained 20% PEG 8000, 0.1 M Tris, pH 8.5, and 0.2 
M MgCl2. Crystals appeared in 7-9 days and exhibited diffraction consistent with the 
space group P21, with two polypeptides per asymmetric unit.                  
Prior to data collection, the crystals of MtOMPDC.H128N•BMP were transferred to 
cryoprotectant solutions composed of their mother liquids and 40% ethylene glycol and 
flash-cooled in a nitrogen stream. The X-ray diffraction data set (Table 16) was 
collected at the NSLS X29A beamline (Brookhaven National Laboratory) on the 315Q 
CCD detector. Diffraction intensities were integrated and scaled with programs DENZO 
and SCALEPACK (7). The data collection statistics are given in Table 16. 
 
Structure Determination and Model Refinement.  The MtOMPDC.H128N•BMP 
structure was solved by molecular replacement with fully automated molecular 
replacement pipeline BALBES (8), using only input diffraction and sequence data. The 
previously determined MtOMPDC•BMP structure (PDB ID 3LTP) was used by BALBES as 
a search model.  The partially refined structure of MtOMPDC.H128N•BMP was the 
output from BALBES. Subsequent several iterative cycles of refinement were performed 
including: model rebuilding with COOT (9), refinement with PHENIX (10), and 
automatic model rebuilding with ARP (11).  
The quality of the final structures was verified with omit maps. The 
stereochemistry was checked with WHATCHECK (12) and MOLPOBITY (13).  The 
program LSQKAB (14) was used for structural superposition. Structural figures with 
electron density maps were prepared using PYMOL (15).  All loops are well-defined in 
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the MtOMPDC.H128N•BMP structure; the electron densities for both BMP ligands in the 
protein dimer are well-ordered; no non-glycine residue lie in disallowed regions of the 
Ramachandran plot. Two protein monomers within dimer are connected by a non-
crystallographic two-fold axis.  Final crystallographic refinement statistics are shown in 
Table 16. 
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Computational Methods 
The wild-type OMPDC simulation system was constructed based on the crystal 
structure of the BMP-bound complex of MtOMPDC (PDB code: 1LOR) (16) as a 
template. In particular, the BMP in the “B” subunit was converted to the protonated 
reaction product uridine monophosphate (UMP), whereas the BMP in the “A” subunit 
was converted to orotidine monophosphate (OMP), which is treated by using a hybrid 
quantum mechanical and molecular mechanical (QM/MM) approach. The orotate group 
was included in the QM region, and the ribose ring C1’ atom was defined as the 
boundary separating the QM region and the MM fragment and treated by the 
generalized hybrid orbital (GHO) method (17) (Chapter 2, Figure 13B). All the 
protein’s histidine residues were considered fully protonated; sodium ions were added 
to ensure global electroneutrality.  
The protein and the ribosylphosphate group in the MM region were represented 
by the CHARMM 22 force field (18) along with the TIP3P model for water. The QM 
region was described by the semiempirical AM1 method. Previous studies have shown 
that the performance of AM1 for the OMP decarboxylation reaction in the gas phase is 
excellent and in quantitative agreement with high-level ab initio molecular orbital 
calculations (CBS) and with density functional theory. The Lennard-Jones parameters 
for atoms in the QM region (19) had been optimized for the AM1 model in QM/MM 
calculations.  All MD simulations were performed at 298.15 K and 1 atm, controlled 
through the Nosé-Hoover thermostat algorithm and the Andersen piston scheme (20-
22). A time-step of 1 fs was used together with the SHAKE (23) (algorithm to constrain 
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all the covalent bond distances involving non-QM hydrogen atoms. The TIP3P water 
model was used to fill a tetragonal box of 69x69X95 Å3; long-range interactions were 
treated with particle mesh Ewald (24) (PME) with a 1 Å mesh. Lennard-Jones 
interactions were switched in the 10 - 11 Å range; the nonbonded lists were updated 
every 25 steps. Before production runs, the system was gradually heated from 20 K to 
298.15 K over 40 ps and then further equilibrated for 35 ps. To study the S127HOS 
substitution, we mutated in silico Ser 127 to L-glycerate in the equilibrated structure, 
further followed by a short equilibration period. To study the effects of the S127HOS 
substitution on the decarboxylation reaction, the backbone of the S127 amide group 
was replaced by an oxygen atom using a structure corresponding to the Michaelis 
complex from the wild-type OMPDC simulations. 
The umbrella sampling (25) technique was used to compute the potential of 
mean force (26) (PMF) along the decarboxylation reaction coordinate (Rc), defined as 
the bond distance between the C6 and C6’ atoms that is cleaved in the decarboxylation 
process. To drive the sampling through the Rc range spanning from 1.4 Å to 3.0 Å, a 
force constant of 20 kcal mol-1 Å-2 was used together with a biasing potential estimated 
from Reference 27 (27).  Each window was subject to 30 ps of equilibration followed by 
180 ps of sampling. Separate simulations, called simulation windows, were performed 
with the harmonic potential placed evenly with 0.2 Å interval in the 1.5 - 2.7 Å range 
along the reaction coordinate.  One additional window was placed at 3.0 Å. A mesh of 
0.02 Å was used to collect the data to obtain the distribution of reaction coordinate 
values and the WHAM (28) algorithm was used to reconstruct the PMF.  
 
 
126 
Trajectories were saved every 100 fs and subject to further analysis. The 
distances between the orotate O4 oxygen and the amide nitrogen of Ser 127, or the 
ester oxygen of glycerate 127 were mapped in the transition state windows and their 
probability densities calculated and plotted. To decompose the contribution of Ser 127 
and its mutant to transition state stabilization/ground state destabilization, we 
computed the interaction energy between this residue and the QM region of the 
substrate in the reactant (R), transition state (TS), and product (P) regions. In the 
scheme employed, the QM energy of the substrate was first computed in the full 
enzyme electrostatic environment, and then it was computed again after the point 
charges of residue 127 were zeroed. The energy difference between these two 
computations is defined as the interaction energy between substrate and residue 127. 
The same approach was employed to calculate energetic contributions only from the 
side-chain of residue 127, from which the backbone interaction energy was derived by 
taking the difference. In all cases the MM atom selections whose charges were zeroed 
were globally neutral. 
 
Mulliken Charges Analysis.  The charge distribution of the substrate of the QM 
region was monitored along the entire reaction by Mulliken population analysis. Similar 
calculations have been performed using an electrostatic potential (ESP) fitting 
procedure both at the Hartree-Fock and MP2 level (results not shown), and the trends 
are consistent with the population analysis.  In Table 9 and Table 10 the charges for 
the Wild-Type (WT) and for the S127Glycerate mutant (MUT) are reported at reaction 
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coordinates corresponding to the Reactant (R), Transition State (TS), and Product (P) 
states. In the active site of the wild-type OMPDC, the carbanion formal charge of the 
decarboxylation product is delocalized throughout the entire pyrimidine ring, with local 
net charges of -0.221 a.u. at C6, -0.358 a.u. on C5H, and -0.255 a.u. on C4=O4, with 
the remaining charge density spread out at other sites. Overall, the charge distribution 
analyses did not show major differences between WT and MUT. The most significant 
change is a shift of electron density of 0.03 a.u. from the C4=O4 carbonyl oxygen 
towards the C6 carbanion. Notice that the net charge on the C5H unit is not affected by 
the S127Glycerate replacement. Nevertheless, the change of the electrostatic 
environment in the mutant affects the free energy barrier (4.7 kcal/mol), and 
interaction energy analyses show that this change is mainly due to the loss of 
stabilization of the TS deriving from S127 backbone hydrogen bond with O4.  
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Supplemental Tables 
 
 
Table 6. Kinetic parameters of OMP decarboxylation for MtOMPDC wild type and 
H128N, measured at 25°C and pH 7.1 
 
 k
cat
 (sec
-1
) KM (µM) kcat/KM (M
-1sec-1) 
Wt 5.3 ± 0.2 1.6 ± 0.5 3.3 X 106 
H128N 3.4 ± 0.24 2.6 ± 0.4 1.3 X 106 
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Table 7. FOMP decarboxylation assay of various proteins produced by in vitro 
expression, carried out at 25°C and pH 7.1 
 
 
 
  
  Volume of in vitro 
reaction in assay 
[FOMP] 
µM 
Vo (M/s) X 
10-8 
a No DNA 10 455 0.5 
b No tRNA 10 455 0.7 
c L-glycerate suppressed 10 455 11 
d L-glycerate suppressed 10 685 10 
e L-glycerate suppressed 10 113 4.1 
f L-Ser suppressed 10 455 320 
g Wt (H128N) 5 455 1026 
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Table 8. Kinetic parameters of FOMP decarboxylation for MtOMPDC H128N and S127Q 
measured at 25°C and pH 7.1 
 
 
  
 kcat (s-1) KM (µM) kcat/KM (M-1s-1) 
H128N 340 ± 40 90 ± 10 (3.8 ± 0.6) x 
106 
S127Q - - 244 ± 19 
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Table 9. Average Mulliken population charges of the pyrimidine ring of OMP substrate 
at the Michaelis complex reactant state (R), at the decarboxylation transition state (TS), 
and at the decarboxylation product state (P) in the active site of wild-type OMPDC. 
 
WT R TS P 
N1 -0.217 -0.213 -0.222 
C6 0.089 -0.146 -0.221 
C2 0.427 0.384 0.363 
O2 -0.358 -0.385 -0.396 
N3 -0.358 -0.377 -0.389 
H3 0.280 0.269 0.260 
C4 0.364 0.335 0.316 
O4 -0.484 -0.532 -0.571 
C5 -0.364 -0.456 -0.510 
H5 0.177 0.170 0.152 
C6' 0.340 0.478 0.451 
OC1 -0.551 -0.359 -0.211 
OC2 -0.548 -0.364 -0.251 
C-Me 0.292 0.291 0.292 
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Table 10. Average Mulliken population charges for the pyrimidine group of OMP at the 
reactant state (R), transition state (TS), and product state (P) in the active site of 
S127HOS. 
 
MUT R TS P 
N1 -0.215 -0.209 -0.209 
C6 0.095 -0.171 -0.257 
C2 0.436 0.395 0.377 
O2 -0.353 -0.381 -0.396 
N3 -0.354 -0.370 -0.381 
H3 0.279 0.267 0.260 
C4 0.365 0.333 0.315 
O4 -0.475 -0.515 -0.541 
C5 -0.350 -0.456 -0.506 
H5 0.174 0.164 0.148 
C6' 0.354 0.473 0.452 
OC1 -0.603 -0.372 -0.207 
OC2 -0.549 -0.361 -0.249 
C-Me 0.288 0.287 0.289 
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Table 11.  Interaction energy (in kcal mol-1) of the QM region of OMP with residue 127 
in the reactant (R), transition state (TS), and product (P) regions of the reaction 
coordinate. The residue interaction energy is further separated in its side chain and 
backbone components. 
 Residue Side Chain Backbone 
WT-R -5.1 -0.8 -4.3 
WT-TS -6.1 0.1 -6.2 
WT-P -6.8 1.6 -8.4 
S127HOS-R 5.8 -1.8 7.6 
S127HOS -
TS 7.7 -1.3 9.0 
S127HOS -P 10.2 -0.2 10.5 
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Table 12. MtOMPDC optimized gene sequence 
>MtOMPDC_optimized 
ATGAACCGCCTGATTCTGGCTATGGACCTGATGAACCGTGATGATGCTCTGCGTGTTACCGGT
GAAGTGCGTGAATACATCGACACTGTGAAAATTGGTTATCCGCTGGTACTGTCTGAAGGCATG
GATATCATTGCTGAATTCCGTAAACGCTTCGGCTGCCGTATCATTGCTGACTTCAAAGTGGCA
GATATCCCGGAAACCAACGAAAAAATTTGTCGTGCGACTTTCAAAGCTGGTGCGGACGCTATC
ATTGTACACGGTTTCCCGGGCGCGGATTCCGTACGTGCTTGCCTGAACGTTGCAGAAGAAATG
GGCCGCGAAGTTTTCCTGCTGACCGAAATGAGCCACCCGGGTGCGGAAATGTTCATCCAGGGC
GCGGCTGACGAAATCGCTCGTATGGGTGTAGATCTGGGCGTTAAAAACTACGTGGGTCCGAGC
ACCCGTCCGGAACGTCTGTCTCGTCTGCGTGAAATCATTGGCCAGGACTCTTTCCTGATCTCC
CCGGGTGTTGGTGCACAGGGTGGCGACCCGGGTGAAACTCTGCGTTTCGCAGATGCGATCATT
GTGGGCCGCTCCATCTATCTGGCGGACAACCCGGCTGCTGCTGCGGCTGGCATCATCGAATCT
ATCAAAGACCTGCTGAACCCGTAA 
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 Table 13. MtOMPDC H128N protein sequence 
 
 
 
  
>MtOMPDC_H128N 
MNRLILAMDLMNRDDALRVTGEVREYIDTVKIGYPLVLSEGMDIIAEFRKRFGCRI
IADFKVADIPETNEKICRATFKAGADAIIVHGFPGADSVRACLNVAEEMGREVFLL
TEMSNPGAEMFIQGAADEIARMGVDLGVKNYVGPSTRPERLSRLREIIGQDSFLIS
PGVGAQGGDPGETLRFADAIIVGRSIYLADNPAAAAAGIIESIKDLLNP 
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Table 14. Primers used for site-directed mutagenesis of MtOMPDC 
 
H128N forward CCTGCTGACCGAAATGAGCAACCCGGGTGCGGAAATGTTCATC 
H128N reverse GATGAACATTTCCGCACCCGGGTTGCTCATTTCGGTCAGCAGG 
S127Amber/H128N 
forward 
TTTCCTGCTGACCGAAATGTAGAACCCGGGTGCGGAAATGTTC 
 
S127Amber/H128N 
reverse 
GAACATTTCCGCACCCGGGTTCTACATTTCGGTCAGCAGGAAA 
T7 forward TAATACGACTCACTATAGGG 
T7 reverse CTAGTTATTGCTCAGCGGTG 
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Table 15. Sequence of amber suppressor tRNA and Flexizyme 
 
 
 
  
Amber 
tRNA 
GGCUCUGUAGUUCAGUCGGUAGAACGGCGGACUCUAAAUCC 
GUAUGUCACUGGUUCGAGUCCAGUCAGAGCCGCCA 
dFx GGAUCGAAAGAUUUCCGCAUCCCCGAAAGGGUACAUGGCGUU 
AGGU 
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Table 16. Data collection and refinement statistics for BMP complex of MtOMPDC 
H128N 
 
 
 
 
 
 
Data collection  
Space group P21 
No. of molecules in asym. 
unit 
2 
Cell dimensions    
    a (Å) 59.96 
    b (Å) 63.70 
    c (Å) 61.74 
   β(˚) 115.30 
  
Resolution (Å) 1.32 
No. of unique                   98758 
reflections  
Rmerge 0.057 
Completeness (%) 99.8 
  
  
Refinement  
Resolution (Å) 25.0-1.32 
Rcryst 0.161 
Rfree 0.178 
No. atoms  
    Protein 3518 
    Waters 521 
Bound ligands BMP, EDO, CL, MG  
Ligands atoms 54 
R.m.s deviations  
    Bond lengths (Å) 0.006 
    Bond angles (°)                                                     1.08
PDB entry                                                                  4LC8
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Supplemental Figures 
 
 
 
Figure 27. Superposition of active-site of MtOMPDC Wt•BMP (cyan) and MtOMPDC 
H128N•BMP (green). The PDB coordinates used for this figure were 3LTP (wt) and 4LC8 
(H128N). The figure was generated using PyMOL Molecular Graphics System 
(Schrödinger, LLC). 
  
S127 
Q185 
R203 
G202 
D75* 
D70 
K72 
BMP 
H/N 128 
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Figure 28. Decay in UV absorbance measured at 300 nm, 25°C, pH 7.1, containing 
455 µM starting concentration of FOMP and 10 µL in vitro protein synthesis reaction 
carried out using a) No template DNA (background); b) S127Amber/H128N template 
DNA in absence of amber tRNA (negative control); and c) S127Amber/H128N template 
DNA in presence of amber tRNA charged with L-glycerate (HOS). 
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Figure 29. Tandem MS/MS analysis of in vitro synthesized wild type (H128N) and 
S127HOS proteins. Panel A, MS/MS fragmentation of parent ion from wild type protein, 
corresponding to the sequence MoxSNPGAEMoxFIQGAADE (residues 126-141). Panel B, 
MS/MS fragmentation of parent ion from S127HOS protein, corresponding to the 
sequence (S→HOS)NPGAEMoxFIQGAADE (residues 127-141). The observed and 
calculated monoisotopic masses (Mr) of the parent ions are indicated on each spectrum. 
Assigned b and y fragment ions are numbered according to the modified Roepstorff & 
Fohlman nomenclature (29, 30). 
 
  
Parent ion: (S!HOS)NPGAEMoxFIQGAADE; Mr (obs)1552.59; Mr (calc)1552.63 
A 
m/z 
B 
Parent ion: MoxSNPGAEMoxFIQGAADE 
Mr (obs)1698.65 
Mr (calc)1698.69  
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Figure 30. Tandem MS/MS analysis of in vitro synthesized protein produced using 
MtOMPDC S127Amber/H128N DNA, in absence of amber suppressor tRNA.  Panel A, 
MS/MS fragmentation of parent ion, corresponding to the sequence 
VFLLTEMox(S→Q)NPGAE. Panel B, MS/MS fragmentation of parent ion, corresponding to 
the sequence Mox(S→Q)NPGAEMoxFIQGAADE. The observed and calculated 
monoisotopic masses (Mr) of the parent ions are indicated on each spectrum. Assigned 
b and y fragment ions are numbered according to the modified Roepstorff & Fohlman 
nomenclature (29, 30). 
  
m/z 
A 
B Parent ion: Mox(S!Q)NPGAEMoxFIQGAADE Mr (obs)1739.72 
Mr (calc)1739.71  
 
Parent ion: VFLLTEMox(S!Q)NPGAE; Mr (obs)1463.66; Mr (calc)1463.7   
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Figure 31. Tandem MS/MS analysis of in vitro synthesized protein produced using 
MtOMPDC S127Amber/H128N DNA and amber suppressor tRNA charged with Ser. Panel 
A, MS/MS fragmentation of parent ion, corresponding to the sequence 
Parent ion: MoxSNPGAEMoxFIQGAADE 
Mr (obs)1698.67; Mr (calc)1698.69  
 
A 
B Parent ion: Mox(S!Q)NPGAEMoxFIQGAADE Mr (obs)1739.68; Mr (calc)1739.71  
 
Parent ion: VFLLTEMox(S!Q)NPGAE;  
Mr (obs) 1463.65; Mr (calc)1463.7  
 
m/z 
C 
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MoxSNPGAEMoxFIQGAADE. Panel B, MS/MS fragmentation of parent ion, corresponding 
to the sequence Mox(S→Q)NPGAEMoxFIQGAADE. Panel C, MS/MS fragmentation of 
parent ion, corresponding to the sequence VFLLTEMox(S→Q)NPGAE. The observed and 
calculated monoisotopic masses (Mr) of the parent ions are indicated on each spectrum. 
Assigned b and y fragment ions are numbered according to the modified Roepstorff & 
Fohlman nomenclature( 29, 30). 
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Figure 32. Distribution of the bond distances between O4 and Ser127 N, or HOS127 O. 
  
 
 
146 
 
 
Figure 33. SDS PAGE purification of in vitro synthesized proteins for mass 
spectrometric analysis. A = Wt (H128N); B = S127Amber/H128N. The bands that 
correspond to the full-length protein used for mass spectrometric analysis are marked 
by (•). 
  
DNA A B -  B B 
tRNA - S - HOS - 
!! !! !! !!
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Figure 34. Radioactive image of SDS-PAGE experiments performed on in vitro protein 
synthesis reactions containing [35S]-methionine. Relative expression levels of the full-
length protein from reactions containing tRNA charged with L-glycerate (HOS) and Ser 
(S) compared to wild type (H128N) are indicated above the respective bands. 
 
 
 
 
 
 
DNA Wt  S127Amber 
Amber 
tRNA 
- S HOS 
100 55 58 
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Supplemental Methods 
 
Assay for Decarboxylation of EO. EO decarboxylation assays were performed by the 
same method as previously published (2). Before performing the assays the enzyme 
was dialyzed exhaustively against 50mM MOPS at pH 7.0 and I=0.179(NaCl). Stock 
concentration of enzyme was determined spectro-photometrically at 280 nm using the 
proteins molar extinction coefficient (5960 M-1cm-1 for Wt and all mutants except ones 
containing Y206F mutation; or 4470 for Y206F containing mutants). The stock 
concentration of EO was determined spectro-photometrically at 267 nm using molar 
extinction coefficient of 9570 M-1cm-1. Stock solutions of enzyme and EO were mixed 
along with buffer (50mM MOPS, pH 7.0; I=0.179) and 0.28 M NaCl to give final reaction 
condition of 25mM MOPS, pH 7.0; I=0.14; final enzyme concentration ranging from 50 
to 500 µM (depending on the mutant) so that the first 5% of the reaction can be 
observed in a reasonable time; and two EO concentrations of 5mM and 10 mM 
respectively. The reaction was carried out at 25° C maintained in a water bath. Aliquots 
from the reaction were taken at regular time intervals. The reaction was quenched by 
diluting the aliquots 10 fold using quenching buffer (2.5 mM formic acid containing 40 
µM 5-fluoro-uracil as internal standard), to give a final pH of 3.8. To remove the 
enzyme; the quenched reaction aliquots were passed through Millipore Biomax 10 kDa 
NMWL, 0.5 mL centrifugal filters pre-rinsed with water. The reaction aliquots were 
analyzed for product formation (1-(β-D-erythrofuranosyl)uracil, EU) by the Beckman 
Gold System HPLC using a 3 µm (3.9 mm x 150 mm) dC18 column (Waters Atlantis) 
and 10 mM ammonium acetate (Fluka), pH 4.2, as the isocratic eluent at a flow rate of 
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1 mL/min. 45 µl of the quenched reaction aliquots were injected and the product 
observed by setting the HPLC UV detector at 262 nM. The EU concentrations formed at 
various times were determined by interpolating the area of the EU peak observed, onto 
a calibration curve generated using uridine (product analog). The calibration curve was 
generated by injecting various dilutions of uridine (5µM to 100µM) in quenching buffer 
on the column and measuring the area of the uridine peak. The exact concentration of 
uridine stock was determined spectro-photometrically at 262 nM using a molar 
extinction coefficient of 10100 M-1cm-1 in 0.1 N HCl. The EU concentration was corrected 
for dilution due to filtration by comparing the area of the internal standard of each 
injection to that of unfiltered “blank”. From the amount of EU formed at different time 
intervals, an initial velocity was determined (M s-1). Second order rate constant (kcat/KM) 
was determined by dividing the initial velocity by the concentration of enzyme and 
substrate used in the reaction. The enzyme was ensured to be active throughout the 
time of the assay by performing OMP decarboxylation assays at the beginning and end 
of the assays. 
 
Assay for Decarboxylation of FEO. FEO decarboxylation assay of MtOMPDC Wt and 
single mutants were performed by observing the first order decay of FEO spectro-
photometrically at 290 nm in a similar way as done for OMP decarboxylation. Stock 
concentration of FEO was determined spectro-photometrically at 270 nm using a molar 
extinction coefficient of 9895 M-1cm-1 in 0.1 N HCl. The first order decay curves were fit 
to obtain the first order rate constant (Vmax/KM.) The second order rates (kcat/KM) was 
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determined by dividing the first order rate constant with the concentration of enzyme 
used in the assay.  
 
FEO decarboxylation assay of multiple mutants were performed using the HPLC based 
assays similar to the one described for EO (2) with slight modifications. The reaction 
conditions and method used to determine product were the same as EO assay, except 
a) the HPLC UV detector was set to detect at 270 nm and b) FEU concentrations were 
determined by interpolating the area of FEU peak observed to the calibration curve 
generated using 5-fluoro-uridine (product analog). The 5-fluoro-uridine stock 
concentration was determined spectro-photometrically at 269 nM using a molar 
extinction coefficient of 9660 M-1cm-1 in 0.1 N HCl. 
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Supplemental Tables 
Table 17. Gene sequence of MtOMPDC wild type protein 
 
  MtOMPDC Wt gene 
ATGAGATCCCGGAGAGTTGATGTTATGGACGTTATGAACAGACTTATACTTGCAATGGAC 
CTCATGAACCGGGATGATGCCCTCAGGGTCACCGGAGAGGTCAGGGAATACATAGACACG 
GTCAAGATAGGGTACCCCCTTGTACTCTCAGAGGGTATGGATATCATTGCTGAGTTCAGA 
AAGAGATTTGGCTGCAGAATCATAGCCGACTTCAAGGTTGCAGATATACCCGAGACCAAT 
GAAAAGATATGCCGGGCCACCTTCAAGGCGGGGGCTGATGCCATAATAGTCCACGGATTC 
CCGGGAGCAGACAGTGTCAGGGCCTGCCTCAATGTCGCAGAGGAAATGGGACGTGAGGTC 
TTCCTCCTGACAGAGATGTCACACCCGGGGGCAGAGATGTTCATACAGGGCGCTGCAGAT 
GAAATAGCCAGAATGGGGGTCGATCTTGGTGTCAAAAATTATGTTGGCCCATCCACAAGA 
CCTGAAAGGCTTTCAAGGCTGAGGGAAATCATAGGTCAGGATTCATTTCTCATATCCCCC 
GGTGTGGGAGCCCAGGGAGGAGACCCAGGGGAGACCCTCAGGTTCGCAGATGCCATAATA 
GTTGGAAGATCCATCTACCTTGCAGATAACCCTGCAGCTGCAGCAGCAGGGATAATAGAA 
TCCATTAAAGACCTTCTGAATCCCTGA 
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Table 18. Protein sequence of MtOMPDC 
 MtOMPDC Wt 
MRSRRVDVMDVMNRLILAMDLMNRDDALRVTGEVREYIDTVKIGYPLVLSEGMDIIAEFR 
KRFGCRIIADFKVADIPETNEKICRATFKAGADAIIVHGFPGADSVRACLNVAEEMGREV 
FLLTEMSHPGAEMFIQGAADEIARMGVDLGVKNYVGPSTRPERLSRLREIIGQDSFLISP 
GVGAQGGDPGETLRFADAIIVGRSIYLADNPAAAAAGIIESIKDLLNP 
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Supplemental Methods 
 
 
Obtaining an initial model of the FrsA/pyruvate complex 
Coordinates for the free enzyme monomer were obtained from the PDB (entry: 3MVE) 
and all crystallographic waters and counter-ions were removed prior to the addition of 
hydrogen atoms using the tLEAP module of the AMBER11 software package (1, 2). The 
resulting structure was placed in a box of explicit TIP3P water molecules (3) with two 
chloride ions to yield a system with zero net charge. After constrained energy 
minimization, the FrsA structure was carefully equilibrated using a series of constrained 
molecular dynamics simulations (NPT ensemble). These calculations all employed the 
AMBER99 force field (4, 5), as implemented in the Sander module of the AMBER11 
software package (1), and the Particle-Mesh Ewald algorithm to treat electrostatic 
interactions (6). Force field parameters for pyruvate were generated using the 
Generalized AMBER Force Field (GAFF) (7), and then the GLIDE tool (8) in the 
MAESTRO package was used to generate models of the FrsA/pyruvate complex. The 
docking calculations employed an active site consisting of the residues (Arg-53, Asp-
203, Arg-272, Phe-273, Phe-303, Tyr-316, Leu-320, Met-338 and Trp-341) proposed in 
the original description of FrsA structure and function (9). Subsequent energy 
minimization of eight FrsA/pyruvate complexes followed by constrained MD equilibration 
(over a period of 40 ns in the NPT ensemble) gave the same final structure, which was 
then used as the starting point for QM/MM simulations (Figure 35). Coordinates for 
this FrsA/pyruvate complex in PDB format (10) are available from the authors on 
request. 
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CPMD simulations of pyruvate decarboxylation in the FrsA/pyruvate complex 
The QM/MM simulations employed an extension of CPMD (12, 13). Atoms in the QM 
region, comprising pyruvate, three active site waters, and the Tyr-316 side chain 
capped at Cα with a monovalent pseudopotential (13), were described by the BLYP 
functional (14, 15) and norm-conserving Martins-Trouiller pseudopotentials (16) with 
dispersion-corrected atom-centered potentials (17-20). Wavefunctions were expanded 
in a plane wave basis set with a 70 Ry cutoff inside an orthorhombic box (37 Å x 22 Å x 
22 Å), and long-range interactions were decoupled using the Martyna-Tuckerman 
scheme (21). The remaining protein atoms and explicit solvent water molecules were 
described by a classical AMBER99 force field (4, 5). QM/MM simulations were performed 
at constant pressure and temperature, using a Nosé Hoover thermostat, after slow 
heating to 300K over 2-3 ps. In these heating simulations, however, the Tyr-316 
hydroxyl spontaneously transferred a proton to the pyruvate carboxylate when the 
temperature exceeded 250 K. Control calculations, using a constraint on the O-H bond 
of the Tyr-316 moiety, demonstrated that the proton transfer event was not due to the 
starting configuration. Thus, when the constraint on the O-H bond was released at 
300K, spontaneous proton transfer again took place. The resulting system containing 
neutral pyruvic acid was then equilibrated for 2 ps before constrained MD simulations 
were performed for thermodynamic integration (22, 23) using a reaction coordinate 
chosen to be the bond distance between C1 and C2 of the pyruvate molecule. Hence, 
constraints were employed at distances spanning 1.55 to 4.24 Å (in increments of 25 
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pm) with sampling at each constrained distance for a period of 1 ps. The free energy 
profile was obtained by integrating the constraint forces over the respective distances. 
 
CPMD simulations of pyruvate decarboxylation in water 
Pyruvate monoanion was placed in a box of explicit TIP3P water molecules (3) with a 
single potassium ion to yield a system with zero net charge, and the resulting system 
equilibrated using a series of MD simulations (over a period of 40 ns in the NPT 
ensemble). These calculations all employed the AMBER99 force field (4, 5), as 
implemented in the Sander module of the AMBER11 software package (1), and the 
Particle-Mesh Ewald algorithm to treat electrostatic interactions (6). GAFF (7) 
parameters were employed to describe pyruvate in these equilibration studies. The 
equilibrated system was then employed in QM/MM simulations (12, 13). Atoms in the 
QM region comprised the pyruvate monoanion and a water molecule, which was 
hydrogen bonded to the carboxylate group of pyruvate. These QM atoms were 
described by the BLYP functional (14, 15) and norm-conserving Martins-Trouiller 
pseudopotentials (16) with dispersion-corrected atom-centered potentials (17-20). 
Wavefunctions were expanded in a plane wave basis set with a 70 Ry cutoff inside an 
orthorhombic box (12 Å x 7 Å x 7 Å), and long-range interactions were decoupled using 
the Martyna-Tuckerman scheme (21). The remaining water molecules were described 
by a classical AMBER99 force field (4, 5). QM/MM simulations were performed at 
constant pressure and temperature, using a Nosé Hoover thermostat, after heating to 
300K. After equilibration, constrained MD simulations were performed for 
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thermodynamic integration (22, 23) using a reaction coordinate chosen to be the bond 
distance between C1 and C2 of the pyruvate molecule. Hence, constraints were 
employed at distances spanning 1.6 to 4.5 Å (in ten increments) with sampling at each 
constrained distance for a period of 1 ps. The free energy profile was obtained by 
integrating the constraint forces over the respective distances 
 
pKa estimates using Poisson-Boltzmann calculations 
The protonation state of all protein residues in the X-ray crystal structure of unliganded 
FrsA (3MVE), the equilibrated model of the FrsA/pyruvate complex, and several 
different “frames” from classical MD trajectories for unliganded FrsA and the 
FrsA/pyruvate complex were calculated (Table 19) using two well-established methods, 
H++ (24, 25) and  Adaptive Poisson-Boltzmann (APB) (26). These calculations suggest 
that the pKa of the Tyr-316 side chain is lowered by approximately one unit when 
pyruvate is bound to the protein (Table 19). Superimposing different MD snapshots of 
the active site is consistent with the view that electrostatic repulsion between the 
substrate carboxylate and the Asp-203 side chain, and steric interactions with Met-312, 
positions pyruvate close to Tyr-316 and Arg-273 (Figure 37). 
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Protein expression and purification 
Method A  
The gene encoding the FrsA from Vibrio vulnificus in the plasmid pQE-FrsA was 
generously provided by Dr. Sun-Shin Cha (Marine Biotechnology Research Center, 
Korean Ocean Research & Development Institute) and expressed in Escherichia coli 
JM109 cells containing the F’ episomal element, as reported previously (9). F’ is 
essential for protein expression, and JM109 cells containing this element were identified 
by screening on minimal growth media containing proline. After transformation with 
pQE-FrsA, starter cultures of JM109 cells were grown overnight in M9 minimal media 
supplemented with thiamin (5 µg/mL), L-proline (5 µg/mL) and ampicillin (100 µg/mL). 
These starter cultures were used to inoculate 3 L of M9 minimal media supplemented 
with thiamin, L-proline and ampicillin (100 µg/mL). The cultures were grown with 
aeration at 37 °C to mid-log phase (O.D of 0.6) and then heat shocked at 42 °C for 15 
min before the addition of IPTG (0.5 mM) to induce protein expression. Cells were 
harvested after 6 h, lysed using sonication, and subsequently centrifuged at 5000x g to 
obtain a clear lysate that was added to Ni-NTA resin suspended in a phosphate wash 
buffer (50 mM NaH2PO4 containing 10 mM imidazole and 500 mM KCl, pH 7). After 1 h 
incubation on ice, FrsA was eluted from the resin (50 mM NaH2PO4 containing 250 mM 
imidazole and 500 mM KCl, pH 7) and protein-containing fractions were pooled and 
dialyzed into 50 mM NaH2PO4 containing 500 mM KCl and 1 mM DTT, pH 7. The 
inclusion of DTT in the elution buffer was to prevent formation of the FrsA dimer by a 
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disulfide bond between the cysteine residues, which had been reported to be inactive 
(9).   
Method B  
The codon-optimized gene encoding the FrsA from Vibrio vulnificus was synthesized 
(GenScript, Piscataway NJ) and ligated into the PUC57 plasmid with NdeI and BamHI 
restriction sites at the 5’ and 3’ ends, respectively. The resulting plasmid was subjected 
to digestion with NdeI and BamHI and ligated into the pET15b expression vector 
(N-terminal His6-tag). The ligated plasmid was transformed into Escherichia coli XL1 
blue cells, and a single colony was inoculated into 5 mL of LB containing ampicillin 
(100µg/mL) and allowed to grow overnight at 37 °C. The plasmid encoding FrsA was 
then transformed into Escherichia coli BL21 (DE3) cells and starter cultures prepared 
from single colonies. These were used to inoculate 4 L of LB containing ampicillin (100 
µg/mL), and resulting cultures were grown at 37 °C with aeration to mid-log phase 
(O.D. ~ 0.6) before the addition of IPTG (1 mM final concentration). Cells were 
harvested after 4 h, and lysed by sonication. The clarified lysate was then loaded onto 
Ni-NTA resin and FrsA eluted using an imidazole gradient. The fractions containing FrsA 
(determined by SDS PAGE) were pooled, dialyzed against phosphate buffered saline 
containing 3 mM DTT, and the His-tag cleaved using thrombin (Promega, Madison WI). 
The resulting preparation of FrsA was dialyzed against storage buffer (20 mM HEPES 
containing 150 mM NaCl and 3 mM DTT, pH 7.5). After concentration to ~ 10 mg/mL, 
the purified FrsA was stored in 20 µL aliquots at -80 °C. 
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Kinetic assays of recombinant, wild type FrsA 
Method A: Membrane-Inlet Mass Spectrometry (MIMS) for direct detection of CO2 
The real-time production of 13CO2 was monitored by MIMS (27) when 1 mM 13C-labeled 
pyruvate was incubated with 50 nM recombinant FrsA dissolved in 50 mM NaH2PO4 
buffer, pH 7, containing 500 mM KCl and 1 mM DTT, over a period of 12 min at 37°C. 
No detectable decarboxylase activity was observed.  
 
Method B: Spectrophotometric assay for pyruvate decarboxylation.  Decarboxylation of 
pyruvate to acetaldehyde was measured using a coupled assay with yeast alcohol 
dehydrogenase (Sigma-Aldrich, St. Louis MO) by monitoring the decay in NADH 
absorbance at 340 nm.  Assays were carried out in 50 mM sodium phosphate, pH 7.0; 
containing 1 mM DTT; 5 mM pyruvate; 0.2 mM NADH; 3.7 units of alcohol 
dehydrogenase and FrsA ranging from 1 nM to 1 µM. No detectable activity was 
observed.  At the end of each assay, acetaldehyde was added to ensure that the 
alcohol dehydrogenase was active. 
 
Method C:  1H NMR detection of the FrsA-catalyzed pyruvate decarboxylation. 1H NMR 
spectroscopy was used to detect acetaldehyde formation when 5 µM FrsA was 
incubated for 90 min at 20 °C with 10 mM pyruvate in D2O with 50 mM phosphate, pD 
7.0, containing 1mM DTT. Although signals corresponding to the methyl group protons 
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of unhydrated and hydrated pyruvate anion were detected, no resonance(s) were 
detected for the protons in acetaldehyde. 
 
Crystallization, data collection, structure determination and crystallographic 
refinement  
Crystals of recombinant, wild type FrsA were grown at room temperature using the 
“sitting drop” method. In these experiments, the protein solution contained FrsA (20 
mg/mL), 150 mM NaCl and 3 mM DTT dissolved in 20 mM HEPES buffer, pH 7.5 and 
the percipient was composed of 20% PEG monomethyl ether 2000 and 200 mM 
trimethylamine N-oxide in 0.1 M Tris buffer, pH 8.5. Crystals appeared in 3-4 days and 
exhibited diffraction consistent with the space group P21, with two polypeptides per 
asymmetric unit. Prior to data collection, the crystals of FrsA were transferred to 
cryoprotectant solutions, composed of their mother liquids containing 20% glycerol, and 
flash-cooled in a nitrogen stream. The X-ray diffraction data set (Table 20) was 
collected at the NSLS X29A beamline (Brookhaven National Laboratory) on the 315Q 
CCD detector. Diffraction intensities were integrated and scaled with programs DENZO 
and SCALEPACK (28). 
 
The FrsA X-ray crystal structure (Figure 38) was solved using only input diffraction and 
sequence data by molecular replacement with the fully automated molecular 
replacement pipeline BALBES (29). The search model employed by BALBES was that of 
a previously reported structure for FrsA (3MVE) (9). After obtaining a partially refined 
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structure from BALBES, several iterative cycles of refinement were then performed. 
Thus, model rebuilding was performed with COOT (30) and refined with PHENIX (31), 
followed by automatic model rebuilding using the ARP software package (32). The 
quality of the final structure was verified with omit maps, and stereochemistry checked 
with WHATCHECK (33) and MOLPOBITY (34). All loops are well defined in the current 
FrsA structure, with only the backbone torsion angles of Asn-108 adopting values in the 
disallowed region of the Ramachandran plot. The program LSQKAB 35) was used for 
structural superposition, and figures with electron density maps were prepared using 
PYMOL. Final crystallographic refinement statistics are shown in Table 20. 
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Supplemental Tables 
 
Table 19. pKa values computed for Tyr-316 in unliganded FrsA (3MVE) and various MD 
trajectory “snapshots” of the FrsA/pyruvate complex, and for pyruvate in the final 
model of the FrsA/pyruvate complex. 
 
a H++ (http://biophysics.cs.vt.edu/H++) 
b APBS (ref. 26)  
 
 
 
 
 
 
 
 
 
Residue Calculated pKa 
(Method A)a 
Calculated pKa 
(Method B)a 
Tyr-316 (3MVE) 
9.6 10.5 
Tyr-316 (FrsA/pyruvate: 18.60 ns) 9.8 9.9 
Tyr-316 (FrsA/pyruvate: 18.75 ns) 9.9 9.9 
Tyr-316 (FrsA/pyruvate: 18.90 ns) 9.0 10.1 
Tyr-316 (FrsA/pyruvate: 19.00 ns) 9.2 9.2 
Pyruvate (FrsA/pyruvate: 19.00 ns) n.d. 3.8 
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Table 20. Crystallographic data collection and refinement statistics.a 
Data Collection 
Resolution (Å) ∞-1.95 
X-ray Source 
NSLS X29A 
Wavelength (Å) 1.075 
Space Group P21 
Molecules in asymmetric unit 2 
Cell dimensions a = 42.66 Å, b = 104.54 Å, c = 82.30 Å,  
β = 91.18o 
Unique reflections observed 51363 
Completeness (%) 97.8 
Rmergeb 0.083 
Refinement 
Protein residues/water atoms 
per asu 
6405/274 
Other ligands per asu 2 
Reflections (work/free) 51363/2608 
Rcryst/Rfree (%) 17.9/22.7 
Resolution (Å) 25.00-1.95 
Average B-factor (Å2) 29.2 
Protein (Å2) 29.3 
Hexanoic acid (Å2) 32.9 
PEG monomethyl ether (Å2) 47.5 
RMSDc Bond lengths (Å) 0.008 
RMSD Bond angles (o) 1.05 
 
a Coordinates are deposited as PDB entry 4I4C. 
b Rmerge = ∑hkl ∑i| Ihkl, i-<Ihkl> I | / ∑hkl∑i | Ihkl, i |, where <Ihkl> is the mean intensity of the 
multiple Ihkl, i observations for symmetry-related reflections. 
c RMSD: root mean square deviation. 
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Supplemental Figures 
 
 
 
Figure 35. Ribbon representation of the FrsA/pyruvate model complex showing the 
location of the bound ligand.  Pyruvate is rendered as cylinders colored by atom type. 
Color scheme: C – cyan; H – white; O – red. The figure was produced with the VMD 
software package (11). 
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Figure 36. Free energy profile (kcal/mol) for cleavage of the pyruvate C-C bond in 
water, as computed by thermodynamic integration. Error bars show the statistical sum 
of errors associated with the calculated free energy. 
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Figure 37. Superimposed snapshots of the active site from the MD trajectory of the 
equilibrated FrsA/pyruvate complex. The average distance between pyruvate and the 
Asp-203 side chain is shown by the dashed line. Residue coloring reflects the time of 
the snapshot, ranging from red (early) to blue (late). 
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Figure 38. Ribbon representation of the FrsA monomer containing putative ligands. 
The N- (1-165) and C-terminal (166-415) domains are colored brown and cyan, 
respectively. Bound PEG monomethyl ether (H3C[OCH2CH2]5OH) and hexanoic acid 
(H3CCH2CH2CH2CH2 COOH) ligands are rendered as cylinders colored yellow and green, 
respectively, except for oxygen atoms, which are shown in red. Bound hexanoate is 
positioned in a very similar manner to pyruvate in the equilibrated computational model 
of the FrsA/pyruvate complex Figure 35. The image was produced with PYMOL (DeLano 
Scientific Software LLC, Palo Alto, CA).  
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